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ABSTRACT
Herpes simplex virus type 1 is a common neurotropic pathogen responsible for a
multitude of human diseases ranging from mucocutaneous lesions, keratitis to life-threatening
encephalitis. The hallmark of the HSV-1 life cycle is infection of sensory neurons, where the
virus establishes a latent infection for the life of the host. Viral envelope glycoproteins play
important roles in viral life cycle and virus-host interaction. Viral glycoproteins gK, gM, gE and
the membrane protein UL11 have been shown to be important for virus assembly, egress and
virus spread. To investigate the relative importance of each of gK, gM, gE and UL11 in infection
of ganglionic neurons following ocular inoculation, recombinant viruses were constructed,
characterized and used to infect mice via the ocular route. Results showed that gK plays the
most important role in infection of ganglionic neurons following ocular inoculation in the
mouse model. gK null viruses exhibited major defects in replication and cell to cell spread in
tissue culture. To further investigate the role of gK in the pathogenesis of herpes keratitis and
to delineate gK domains responsible for replication and neuroinvasion, recombinant viruses
lacking the amino-terminus of gK were constructed. Characterization of the constructed viruses
revealed that the amino terminus of gK is dispensable for replication in tissue culture; however,
it is required for neuroinvasion and cell to cell spread. Moreover, the virus lacking the amino
terminus in gK was unable to infect corneal epithelium and establish latency in the trigeminal
ganglia after ocular inoculation of mice. In the above mentioned investigation, we have
observed that lack of the amino terminus of gK is associated with lack of ocular disease in
infected mice. Further investigation of this observation (still in progress) revealed a potential
role for gK in the immunopathogenesis of keratitis. The research work presented in this
xi

dissertation is of paramount importance as it identifies gK as an important neurotropic
determinant,

and

it

delineates

gK

domains

responsible

for

neuroinvasion

and

immunopathogenesis in vivo. This work may lead to the development of replication competent,
safe vaccine vectors, and paves the way for the discovery of new therapeutics for herpes
keratitis.
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CHAPTER I: INTRODUCTION
Statement of Problem and Hypothesis
Herpes simplex virus type 1 causes multiple medical disorders such as oral lesions,
keratitis, encephalitis and systemic disease. A characteristic feature of the HSV-1 life cycle is
infection of sensory neurons, where the virus establishes a latent infection in the trigeminal
ganglia. The infection starts at the mucocutaneous areas (site of exposure) followed by entry
into the axonal termini of sensory neurons. The virus recruits cellular transport machinery to
translocate in retrograde manner to the body of the neuron. In the neuronal cell body, the virus
remains latent for the life of the host. Although not completely understood, exposure to ultra
violet (UV) light or immunosuppression leads to bouts of reactivation whereby the virus
transports in anterograde manner to the primary site of infection. HSV-1 is the leading cause of
infectious blindness in the developed world; there is an estimated 400,000 people suffer from
herpes ocular disease in the United States. Recurrent herpes keratitis leads to corneal opacity
and vision loss. Also, reactivation of latent virus from the trigeminal ganglia (TG) can cause
spread to corneal transplants causing corneal graft failure.
Herpes viruses consist of a dense double stranded DNA core enclosed in an icosahedral
capsid. The capsid is surrounded by proteinaceous tegument and an envelope derived from
cellular membranes. The envelope contains 12 glycoproteins that function in multiple aspects
of viral life cycle, and virus-host interactions. The virus uses a core fusion complex composed of;
gB, gH/gL, and gD, and the accessory proteins gK and UL20p for optimal fusion. gB and gH/gL
are conserved among all Herpesviruses. Although not conserved, gD has functional homologues
1

in all herpesviruses. gK is conserved among alphaherpesviruses (neurotropic viruses). The
envelope protein gK is involved in virion egress, envelopment, and viral fusion and syncytia
formation. Viral glycoproteins gK, gM, gE and the membrane protein UL11 have been shown to
be important for virus assembly, egress and virus spread. Research in this laboratory has
uncovered an important role for gK in neuroinvasion. However, the recombinant gK null viruses
that were constructed previously to study gK function exhibited major defects in replication and
cell to cell spread in tissue culture, which are considered unfavorable qualities for vaccine
vector development. The hypothesis promulgated in this dissertation is that a functional
hierarchy among viral membrane proteins exists with respect to their importance in viral life
cycle and virus-host interaction in vivo. We also hypothesize that gK structure can be divided
into functional domains each of which confers distinct characteristics on virus properties. The
hypothesis predicts that the amino terminus of gK, which contains two N-glycosylation sites, is
necessary for viral neurtropism and the fusion process during virion entry as well as for
immunopathogenesis.
Statement of Research Objectives
The first goal of this research was to explore the relative functional importance of a
subset of viral membrane proteins in their role in ocular pathogenesis and establishment of
latency in ganglionic neurons. The second goal was to assess the role of the amino terminus of
gK in neuroinvasion and immunopathogenesis of keratitis as well as virus replication and
spread.
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The specific aims of this research include:
I.

To investigate the relative importance of each of gK, gM, gE and the membrane protein
UL11 in infection of ganglionic neurons following ocular inoculation of mice.
a. To fully characterize the constructed recombinant viruses that lack the
expression of either gK, gM, gE or the membrane protein UL11 in tissue culture
by analyzing viral growth kinetics and plaque morphology.
b. To assess whether the lack of either gE, gM, gK or UL11 affects the clinical ocular
disease development and viral shedding.
c. To determine whether gK-null, gE-null, gM-null, and UL11-null viruses infect
ganglionic neurons and establish latency.

II.

To delineate the role of the amino terminus of gK in neuro-invasion and pathogenesis of
herpes keratitis.
a. To construct recombinant herpes simplex virus type one on a McKrae
background lacking the amino terminus of gK using a two-step Red
recombination Bacterial Artificial Chromosome mutagenesis system.
b. To fully characterize the newly constructed viruses in tissue culture by analyzing
viral growth kinetics and plaque morphology.
c. To assess the role of the amino-terminus of gK in neuroinvasion and ocular
pathogenesis in a scarified cornea mouse model (in vivo).
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d. To monitor ocular clinical disease progression and score the severity of ocular
disease.
e. To determine whether viral DNA genomes of the recombinant virus lacking the
amino terminus of gK and the wild type virus, can be detected in the trigeminal
ganglia.
f. To determine if infectious virions can be recovered from ganglionic neurons after
ocular inoculation of mice.
g. To further investigate the role of the amino terminus of gK in the pathogenesis
of keratitis.
Overall, the results obtained from this work indicate that:
I.

Glycoprotein K plays the most important role among gM, gE, and UL11 in infection of
ganglionic neurons and establishment of latency.

II.

The mutant viruses lacking either gE, gM, gK or UL11, did not cause significant clinical
ocular symptoms and had reduced viral shedding titers than the wild type virus.

III.

The wild type virus and recombinant HSV-1 viruses lacking either gE, gM, or UL11 were
able to infect ganglionic neurons and establish latency. However, gK-null virus was
unable to infect axonal termini and establish latency in the body of ganglionic neurons.
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IV.

UL11-null virus replicated in mouse eyes and Vero cell monolayers less efficiently than
gM-null and gE null mutants; however, it infected ganglionic neurons and established
latency more efficiently than either the gM or gE-null viruses.

V.

A recombinant herpes virus type 1 lacking the amino terminus of gK replicates efficiently
in tissue culture; however, consistently produced significantly smaller plaques than the
parental virus. Therefore the amino terminus of gK is dispensable for replication in
tissue culture but important for cell to cell spread in vitro.

VI.

HSV-1 McKrae wild type virus causes severe keratitis, conjunctivitis and blepharitis
whereas a virus lacking the amino terminus of gK did not cause significant ocular
changes.

VII.

The virus lacking the amino terminus of gK was unable to infect axonal termini and
establish latency in the trigeminal ganglia after ocular inoculation. This result suggests
that the amino terminus portion of gk is the domain responsible for its function in
neuroinvasion.

The work presented here is placed into individual chapters in a manuscript format with chapter
titles reflecting the central theme of the research contained therein.
Chapter III: Functional hierarchy of herpes simplex virus type-1 membrane proteins in
corneal infection and virus transmission to ganglionic neurons.
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Chapter IV: A replication competent HSV-1(McKrae) with a mutation in the aminoterminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea
infection.
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CHAPTER II: LITERATURE REVIEW
History of Herpesviruses
Herpesviruses are ancient pathogens co-evolved with their hosts for millions of years
(Kolb et al., 2013). Due to this long herpesvirus-host relationship, phylogenetic analysis of
Herpesviruses have been used recently as a surrogate biomarker to study human population
structure and past migration patterns throughout history (Kolb et al., 2013) (McGeoch et al.,
2000). The earliest accounts that describe herpes virus infections date back to a Sumerian
tablet approximately 3000 BCE and in the Ebers Papyrus circa 1500 BC (Roizman et al., 2007;
Roizman and Whitley, 2001). The Greek word “Herpes” or Herpin was used by Hippocrates to
describe the skin lesions that creep or crawl. However at that time, herpes was applied to many
different skin ailments (Roizman et al., 2007; Wildy, 1973).
In the 18th century, the French physician John Astruc, in his capacity as a physician for
King Louis XIV, was the first to describe herpes genitalis by studying skin afflictions of French
prostitutes. He published his description of genital herpes in his book De Morbis Venereis in
1736 (Roizman et al., 2007). In 1883, Paul Gerson Unna described herpes skin lesions as a
“vocational disease” of women and also provided descriptions for the recurrences of genital
lesions (Roizman et al., 2007; Roizman and Whitley, 2001). Shortly after that; Les Herpes
Denitaux, the first book specifically devoted to herpes, was published by Charles-Paul Diday and
Adrien Doyon in 1886.
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A decade later, Jean Alfred Fournier wrote about the diagnosis, treatment and
prevention of genital herpes infections; his recommendations were to abstain from alcohol,
tobacco and “sexual excesses”. Evidence for the contagious nature of herpes infections was
provided by the French dermatologist Jean Baptiste Émile Vidal as he showed that vesicular
lesions can be transmitted form one patient to another, and from one anatomical location to
another in the same individual. Vidal used human volunteers in his experiments. Wilhelm
Grüter however, used rabbits as animal models to demonstrate that HSV serially transmitted
between rabbits. Grüter is credited by the virology community for the isolation of HSV (Gruter,
1924; Roizman et al., 2007).
HSV has been recognized as an infectious agent in the late 1800s; however, the
connection between HSV and recurrent infections was not established until 1930s. Andrews
and Carmichael have made the observation that recurrent infections occurred only in adults
who have been previously infected with the virus evidenced by the presence of neutralizing
antibodies (Roizman et al., 2007; Roizman and Whitley, 2001). Burnet and Williams articulated
the modern view on latency in 1939; the virus remains latent after infection, and stimuli such as
trauma or fever, provoke reactivation and visible herpetic lesions (Burnet, 1939). In 1971 and
over 40 years after Grüter’s original isolation of HSV, Schneweis and Nahmias demonstrated the
existence of two separate serotypes of HSV and their association with either orolabial herpes
(HSV-1) or genital herpes (HSV-2)(Roizman et al., 2007; Schneweis and Nahmias, 1971). The
discovery of Acyclovir in the 1980’s dramatically increased the public awareness for genital
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herpes; however, the stigmatization of the condition was overshadowed by the arrival of the
human immunodeficiency virus and the public concerns of a global HIV epidemic (Cuatrecasas,
2006; Kimberlin, 2014).
During the first half of the 20th century, advancements in tissue culture techniques and
virus isolation methods have enabled us to isolate and identify viruses with relative ease.
Varicella-zoster virus (VZV) and human cytomegalovirus (CMV) were isolated in the 1950s, and
the developments in the cultivation of B lymphocytes resulted in the discovery of Epstein-Barr
virus (EBV) in 1964 (Craig et al., 1957; Epstein et al., 1964; Weller and Stoddard, 1952).
Developments in T lymphocytes cell culture techniques allowed for the isolation and
identification of Human Herpesviruses 6A, 6B and 7 in the late 1980s (Frenkel et al., 1990;
Lopez et al., 1988; Salahuddin et al., 1986). Kaposi’s sarcoma-associated herpesvirus (KSHV) or
human herpesvirus 8 (HHV-8) was discovered in 1994 using representational difference analysis
(RDA). This novel technique –at that time- was utilized to identify sequence differences
between two complex genomes (Chang et al., 1994).
The rapid advances in molecular biology and sequencing technologies in the last decade
will undoubtedly revolutionize our understanding of the inner working of known viruses and
facilitate the discovery of a plethora of new viruses (Hall, 2007).
Taxonomy of Herpesviruses
Taxonomy is the science of systematic classification of biological organisms into Taxa, or
groups, based on shared characteristics (Davison, 2010; Fenner, 1976). Biological organisms are
classified so that hierarchical level “domain” is the most inclusive taxonomic rank, whereas
9

virus classification system employs the hierarchical levels of Order, Family, Subfamily, Genus,
and Species. Classification of viruses is managed and standardized by the committee of the
Virology Division of the International Union of Microbiological Societies known as International
Committee on Taxonomy of Viruses (ICTV). ICTV has produced nine reports published in
intervals since it was established in 1971. These reports contain developments in virus
taxonomy (Davison, 2010). In early days, classification of viruses was based on host range and
broad pathogenic and epidemiological features, however, technological advances in molecular
biology and tissue culture as well as the growing use of electron microscopy and
physicochemical methods enabled more accurate viral identification and classification. The
development of specific antibodies enabled the study of antigenic relationships and allowed
researchers to differentiate between closely related viruses (Davison, 2010). Advances in
nucleic acid sequencing and the broad utility of this approach enhanced our ability to
differentiate between closely related species at higher resolution and rationalized taxonomy;
which eventually lead to the adoption of sequence-based phylogenetic analysis as the key
determinant for classification of living organisms (Davison, 2010).
The genus herpesvirus was established in the first ICTV report in 1971 (International
Committee on Nomenclature of Viruses. and Wildy, 1971). The genus consisted of 4 groups and
23 viruses. In the second ICTV report in 1976, Herpesvirus genus was elevated to the family
Herpetoviridae. The second report also added Human herpesvirus 2 as a close relative of
Human herpesvirus 1 to the genus Herpesvirus. To avoid the misleading association of this
family name with reptiles, ICTV renamed Herpetoviridae to Herpesviridae in the third report in
1979. The third ICTV report also subdivided the Herpesviridae family into three subfamilies;
10

Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae(Matthews, 1979). In the ICTV
release in 2008, a new order, Herpesvirales, was introduced and the family Herpesviridae and
the new families Alloherpesviridae and Malacoherpesviridae were created (Davison, 2010;
Davison et al., 2009). Herpesviridae includes viruses of mammals, birds and reptiles, and the
family Alloherpesviridae encompasses viruses that infect fish and frogs, while the family
Malacoherpesviridae incorporates viruses that infect molluscs (Davison et al., 2009).
Members of Alphaherpesvirinae subfamily share several common characteristics; ability
to infect neuronal cells and establish latency in cell bodies, variable host range, efficient lytic
phase of infection in epithelial cells and other non-neuronal cells, relatively short replication
cycle and efficient cell to cell spread. Members of Betaherpesvirinae share several common
characteristics; establish latency in secretory glands, lymphoreticular cells and kidneys, a slow
life cycle, restricted host range and cytomegaly (enlarged infected cells). Members of
Gamaherpesvirinae have several common features which include; they maintain latency in
lymphoid tissue, infect a limited host range, replicate in lymphoblastoid cells in tissue culture,
some members has a lytic replication in epithelial cells and fibroblasts (Roizman et al., 2007).
The most recent online version of the official ICTV taxonomy released in 2013
recognizes a total of 2827 viral species, while the order Herpesvirales currently is home for 3
families, 3 subfamilies, 19 genera and 102 species (table 2-1).
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Table 2.1: Classification of herpesviruses. Adapted with permission from PhD dissertation titled
“The Role of Viral Glycoproteins and Tegument Proteins in Herpes Simplex Virus Type 1
Cytoplasmic Virion Envelopment” by Dmitry V. Chouljenko, Louisiana State University, School of
Veterinary Medicine, Department of Pathobiological Sciences, August 2014. This table was
originally adapted with permission from [Veterinary Microbiology 143(1-2): 52-69, Herpesvirus
systematics]. Copyright (2010) Elsevier. Table has been updated with data from the 2013 ICTV
virus taxonomy release available at ictvonline.org. Asterisks indicate the type species in each
genus.
Taxon name
Order Herpesvirales
Family Alloherpesviridae
Genus Batrachovirus
Ranid herpesvirus 1*
Ranid herpesvirus 2
Genus Cyprinivirus
Anguillid herpesvirus 1
Cyprinid herpesvirus 1
Cyprinid herpesvirus 2
Cyprinid herpesvirus 3*
Genus Ictalurivirus
Ictalurid herpesvirus 1*
Ictalurid herpesvirus 2
Acipenserid herpesvirus 2
Genus Salmonivirus
Salmonid herpesvirus 1*
Salmonid herpesvirus 2
Salmonid herpesvirus 3
Family Herpesviridae
Subfamily Alphaherpesvirinae
Genus Iltovirus
Gallid herpesvirus 1*
Psittacid herpesvirus 1
Genus Mardivirus
Anatid herpesvirus 1
Columbid herpesvirus 1
Gallid herpesvirus 2*
Gallid herpesvirus 3
Meleagrid herpesvirus 1

Common name

Acronym

Lucké tumor herpesvirus
Frog virus 4

RaHV1
RaHV2

Eel herpesvirus
Carp pox herpesvirus
Goldfish haematopoietic necrosis virus
Koi herpesvirus

AngHV1
CyHV1
CyHV2
CyHV3

Channel catfish virus
Black bullhead herpesvirus
White sturgeon herpesvirus 2

IcHV1
IcHV2
AciHV2

Herpesvirus salmonis
Oncorhynchus masou herpesvirus
Epizootic epitheliotropic disease virus

SalHV1
SalHV2
SalHV3

Infectious laryngotracheitis virus
Pacheco's disease virus

GaHV1
PsHV1

Duck enteritis virus
Pigeon herpesvirus
Marek's disease virus type 1
Marek's disease virus type 2
Turkey herpesvirus

AnHV1
CoHV1
GaHV2
GaHV3
MeHV1
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(Table 2.1 continued)
Taxon name
Genus Scutavirus
Chelonid herpesvirus 5*
Genus Simplexvirus
Ateline herpesvirus 1
Bovine herpesvirus 2
Cercopithecine herpesvirus 2
Human herpesvirus 1*
Human herpesvirus 2
Leporid herpesvirus 4
Macacine herpesvirus 1
Macropodid herpesvirus 1
Macropodid herpesvirus 2
Papiine herpesvirus 2
Saimiriine herpesvirus 1
Genus Varicellovirus
Bovine herpesvirus 1
Bovine herpesvirus 5
Bubaline herpesvirus 1
Canid herpesvirus 1
Caprine herpesvirus 1
Cercopithecine herpesvirus 9
Cervid herpesvirus 1
Cervid herpesvirus 2
Equid herpesvirus 1
Equid herpesvirus 3
Equid herpesvirus 4
Equid herpesvirus 8
Equid herpesvirus 9
Felid herpesvirus 1
Human herpesvirus 3*
Phocid herpesvirus 1
Suid herpesvirus 1
Unassigned species in the subfamily
Chelonid herpesvirus 6
Subfamily Betaherpesvirinae
Genus Cytomegalovirus
Aotine herpesvirus 1
Cebine herpesvirus 1
Cercopithecine herpesvirus 5

Common name

Acronym

Chelonid fibropapilloma-associated
herpesvirus

ChHV5

Spider monkey herpesvirus
Bovine mammillitis virus
Simian agent 8
Herpes simplex virus type 1
Herpes simplex virus type 2
Leporid herpesvirus 4
B virus
Parma wallaby herpesvirus
Dorcopsis wallaby herpesvirus
Herpesvirus papio 2
Marmoset herpesvirus

AtHV1
BoHV2
CeHV2
HHV1
HHV2
LeHV4
McHV1
MaHV1
MaHV2
PaHV2
SaHV1

Infectious bovine rhinotracheitis virus
Bovine encephalitis herpesvirus
Water buffalo herpesvirus
Canine herpesvirus
Goat herpesvirus
Simian varicella virus
Red deer herpesvirus
Reindeer herpesvirus
Equine abortion virus
Equine coital exanthema virus
Equine rhinopneumonitis virus
Asinine herpesvirus 3
Gazelle herpesvirus
Feline herpesvirus 1
Varicella-zoster virus
Harbour seal herpesvirus
Pseudorabies virus

BoHV1
BoHV5
BuHV1
CaHV1
CpHV1
CeHV9
CvHV1
CvHV2
EHV1
EHV3
EHV4
EHV8
EHV9
FHV1
HHV3
PhoHV1
SuHV1

Lung-eye-trachea disease-associated
virus

ChHV6

Herpesvirus aotus type 1
Capuchin herpesvirus AL-5
Simian cytomegalovirus

AoHV1
CbHV1
CeHV5
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(Table 2.1 continued)
Taxon name
Human herpesvirus 5*
Macacine herpesvirus 3
Panine herpesvirus 2
Papiine herpesvirus 3
Saimiriine herpesvirus 4
Genus Muromegalovirus
Murid herpesvirus 1*
Murid herpesvirus 2
Murid herpesvirus 8
Genus Probiscivirus
Elephantid herpesvirus 1*
Genus Roseolovirus
Human herpesvirus 6A*
Human herpesvirus 6B
Human herpesvirus 7
Unassigned species in the subfamily
Caviid herpesvirus 2
Suid herpesvirus 2
Tupaiid herpesvirus 1
Subfamily Gammaherpesvirinae
Genus Lymphocryptovirus
Callitrichine herpesvirus 3
Cercopithecine herpesvirus 14
Gorilline herpesvirus 1
Human herpesvirus 4*
Macacine herpesvirus 4
Panine herpesvirus 1
Papiine herpesvirus 1
Pongine herpesvirus 2
Genus Macavirus
Alcelaphine herpesvirus 1*
Alcelaphine herpesvirus 2
Bovine herpesvirus 6
Caprine herpesvirus 2
Hippotragine herpesvirus 1
Ovine herpesvirus 2
Suid herpesvirus 3
Suid herpesvirus 4
Suid herpesvirus 5

Common name
Human cytomegalovirus
Rhesus cytomegalovirus
Chimpanzee cytomegalovirus
Baboon cytomegalovirus
Squirrel monkey cytomegalovirus

Acronym
HHV5
McHV3
PnHV2
PaHV3
SaHV4

Murine cytomegalovirus
Rat cytomegalovirus
English rat cytomegalovirus

MuHV1
MuHV2
MuHV8

Elephant endotheliotropic herpesvirus

ElHV1

Human herpesvirus 6A
Human herpesvirus 6B
Human herpesvirus 7

HHV6A
HHV6B
HHV7

Guinea pig cytomegalovirus
Pig cytomegalovirus
Tupaiid herpesvirus

CavHV2
SuHV2
TuHV1

Marmoset lymphocryptovirus
African green monkey EBV-like virus
Gorilla herpesvirus
Epstein–Barr virus
Rhesus lymphocryptovirus
Herpesvirus pan
Herpesvirus papio
Orangutan herpesvirus

CalHV3
CeHV14
GoHV1
HHV4
McHV4
PnHV1
PaHV1
PoHV2

Wildebeest-associated malignant
catarrhal fever virus
Hartebeest malignant catarrhal fever
virus
Bovine lymphotropic herpesvirus
Caprine herpesvirus 2
Roan antelope herpesvirus
Sheep-associated malignant catarrhal
fever virus
Porcine lymphotropic herpesvirus 1
Porcine lymphotropic herpesvirus 2
Porcine lymphotropic herpesvirus 3

AlHV1
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AlHV2
BoHV6
CpHV2
HiHV1
OvHV2
SuHV3
SuHV4
SuHV5

(Table 2.1 continued)
Taxon name
Genus Percavirus
Equid herpesvirus 2*
Equid herpesvirus 5
Mustelid herpesvirus 1
Genus Rhadinovirus
Ateline herpesvirus 2
Ateline herpesvirus 3
Bovine herpesvirus 4
Cricetid herpesvirus 2
Human herpesvirus 8
Macacine herpesvirus 5
Murid herpesvirus 4
Murid herpesvirus 7
Saimiriine herpesvirus 2*
Unassigned species in the subfamily
Equid herpesvirus 7
Phocid herpesvirus 2
Saguinine herpesvirus 1
Unassigned species in the family
Iguanid herpesvirus 2
Family Malacoherpesviridae
Genus Aurivirus
Haliotid herpesvirus 1*
Genus Ostreavirus
Ostreid herpesvirus 1*

Common name

Acronym

Equine herpesvirus 2
Equine herpesvirus 5
Badger herpesvirus

EHV2
EHV5
MusHV1

Herpesvirus ateles strain 810
Herpesvirus ateles
Bovine herpesvirus 4
Pygmy rice rat herpesvirus
Kaposi’s sarcoma-associated
herpesvirus
Rhesus rhadinovirus
Murine herpesvirus 68
Wood mouse herpesvirus
Herpesvirus saimiri

AtHV2
AtHV3
BoHV4
CrHV2
HHV8

Asinine herpesvirus 2
Phocid herpesvirus 2
Herpesvirus saguinus

EHV7
PhoHV2
SgHV1

Iguana herpesvirus

IgHV2

Abalone herpesvirus

AbHV1

Oyster herpesvirus

OsHV1

McHV5
MuHV4
MuHV7
SaHV2

A definition of a virus species was first created by van Regenmortel in 1989. He defined
a virus species as “a polythetic class of viruses that constitute a replicating lineage and occupy a
particular ecological niche”. The ICTV adopted this definition in 1991, and formalized for the
first time the concept of virus species in its 7th report. A formal system for naming
herpesviruses was founded before 1979 with a number of changes taking place over the
following years. Herpesvirus nomenclature system maintained that herpesviruse species is
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named after the taxon (family or subfamily) of its primry natural host, however,
humanherpesviruses maintained human as a designation instead of hominid. This host-derived
term is followed by the word herpesvirus, and an Arabic number (1973; Davison, 2010; Fenner,
1976; Matthews, 1979; Roizman et al., 1981; Roizmann et al., 1992). Herpesviruses have been
classified as distinct species if “(a) their nucleotide sequences differ in a readily assayable and
distinctive manner across the entire genome and (b) they occupy different ecological niches by
virtue of their distinct epidemiology and pathogenesis or their distinct natural hosts”(Davison,
2010).
Currently, as phylogenetic analysis based on sequence comparison data has
revolutionized biology, and is being used as the basis of taxonomic classification. The ICTV
Herpesvirales Study Group is considering updates in Herpesviruse taxonomy scheme, and to
accommodate the need to classify the rapidly growing number of herpesviruses that have been
detected only by polymerase chain reaction (PCR). The ICTV makes the distinction between the
Virus and Virus species; virus refers to the “real physical entities produced by biological
evolution and genetics”, it can be manipulated and can be further subdivided into more
granular units such as; strains, variants and isolates. Virus species, on the other hand, refers to
the “abstract concepts produced by rational thought and logic”.
Structure of Herpes Virion
A mature herpes virion ranges from 120-300 nanometer (nm) in diameter. It is
composed of 4 distinct structural components; an electron dense core of double stranded DNA,
a capsid shaped as convex polyhedron, a tegument layer and an envelope (Figure 2.1).
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A

B

Figure 2.1: The Structure and morphology of herpesvirus. A mature herpes virion ranges from
120-300 nanometer (nm) in diameter The herpes virion is composed of a dense core containing
double stranded DNA genome enclosed in an icosahedral nucleocapsid, the nucleocapsid is
surrounded by a proteinaceous material called tegument which is further surrounded by a
double-layer membrane called the envelope containing glycoproteins. (A) Schematic diagram
for herpesvirus structure. Image from: http://www.twiv.tv/virus-structure/ (B) electron
micrograph of a mature HSV-1 virion, bar = 100 nm (Mettenleiter et al., 2009).
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Herpesvirus DNA genome in general ranges from 120 kbp to 250 kbp; Herpes simplex
virus genome is 152 kbp long. This DNA core is organized in a toroidal shape or a circle. The
DNA is enclosed in a T- 16 symmetrical icosahedral capsid composed of 162 capsomeres. The
capsid is surrounded by a proteinaceous material called the tegument which is further
surrounded by a double layered envelope derived from cellular membranes. The envelope
contains a dozen of glycoproteins and non-glycosylated membrane proteins.
The interactions between the capsid, tegument and envelope proteins help bring the
virion particle together during viral assembly and stabilize virion structure. They also facilitate
viral protein functions in various steps of viral lifecycle. Interactions between viral envelope
proteins and cell membrane receptors facilitate viral binding, attachment and entry in to cells,
capsid and tegument proteins also interact with cellular transport proteins to convey the capsid
to the nucleus. The interactions between viral proteins and cellular components help
perpetuate the HSV-1 life cycle in uninfected cells (Mettenleiter, 2004; Roizman et al., 2007).
HSV-1 genome:
Herpesvirus genome is packaged inside the capsid in the shape of a tourus. This toroidal
structure (doughnut) is approximately 50 nm high, with an outside diameter of 70 nm and an
inside diameter of 18 nm (Nazerian, 1974). Herpes simplex virus type one has a double
stranded DNA genome, approximately 152 kbp in length with slight variations between
different HSV-1 isolates, and it weighs approximately 100x106 Daltons (Kieff et al., 1971).
Cytosine + Guanine content in herpesviruses ranges from 31 % -75 % across the genome. HSV-1
genome has a relatively high (68%) cytosine (C) + guanine (G) content. Varicillozooster, another
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alphaherpesvirus, for example; has a 46 % genomic G+C content (Baines and Pellett, 2007;
Roizman et al., 2007). Herpesvirus genome is arranged into a unique long (UL or UL) and unique
short (US or US) segments, flanked by terminal repeats (TR) on each terminus. The UL and US
segments are separated by apposed internal repeats (IR) (Figure 2.2) (Roizman et al., 2007).

Figure 2.2: Herpesvirus genome: a schematic representation of the prototypical arrangement of
Herpesvirus genome. It consists of Unique long (UL), and unique short (US) portions flanked by
terminal repeats (TR) and internal repeats (IR). Modified from [mBio 10.1128/mBio.00144-12, A
herpes simplex virus 1 (McKrae) mutant lacking the glycoprotein K gene is unable to infect via
neuronal axons and egress from neuronal cell bodies] (David et al., 2012).
The repeated sequences flanking the UL segment are approximately 9000 bp in length,
whereas, the repeated sequences surrounding the unique short segment are shorter at
approximately 6000-7400 bp. The repeats, terminal and internal, are able to invert to one
another to form four isomers arranged in varying orientations. These reiterated sequences
generally, regulate the expression of several genes (Roizman et al., 2007). ICP0 for example, is
present in the repeats flanking the unique long segments and is one of the most conserved
genes in the long repeated sequences. ICP4 is one of the most conserved genes in the repeated
sequences that flank the US segments. Both genes are immediate-early genes that function in
regulation of viral and host cell gene expression and are important for reactivation of latent
herpes simplex viruses (Baines and Pellett, 2007; Everett, 2000; Liu et al., 2010).
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Most of herpesvirus genes are composed of a 50-200 bp promoter region, followed by a
TATA box and an initiation site of 20-25 bases. A 30-300 bases spacer is present between the
TATA box and a 5’ untranslated leader sequence. This leader sequence is followed by the major
open reading frame (ORF) which is followed by 3’ untranslated segment, 10-30 bases long, and
a polyadenylation sequence. HSV-1 encodes approximately 90 open reading frames (ORF), the
majority of which (over 80%) are not spliced. Herpesviruses also produce noncoding RNAs. A
well-studied example of these non-coding RNAs is the Latency Associated Transcript (LAT). It is
difficult to determine the exact number of encoded proteins in Herpesviruses because some
herpesvirus genes do not have a TATA box, possess a second initiation sites and show a
disregard of predicted transcription termination sites for several late genes; nonetheless, there
are approximately 84 transcriptional units participating in the production of herpes simplex
type 1 viral proteins (Davison, 2007; Mavromara-Nazos and Roizman, 1989; McGeoch et al.,
2006; Roizman et al., 2007).
The UL region of herpesvirus genome encodes genes that tend to be more conserved
among alphaherpesviruses than genes encoded by the US segment. Enzymes that are necessary
for viral replication and metabolism are the most conserved and are encoded by the unique
long segment; examples include UL5, UL15, UL30 and UL40. (Baines and Pellett, 2007; Roizman
et al., 2007).
A number of genes are conserved among all herpesviruses such as gB. Other genes are
only shared by alphaherpesviruses such as gK. A few genes unique to HSV-1 and HSV-2 and not
shared with other alphaherpesviruses also exist. Important examples are γ1 34.5 and US11;
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they encode a 263 aa and a 161 aa proteins, respectively. US11 is a dsRNA-binding protein; it
antagonizes the action of double-stranded RNA-dependent protein kinase (PKR) and inhibits
stress-induced translational arrest. γ1 34.5 has been implicated in the inhibition of autophagy
and in the de-phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α) in order to prevent shutoff of viral protein synthesis by the action of activated PKR (He et
al., 1997; Lussignol et al., 2013; Roizman et al., 2007).
Unique to herpes simplex viruses, type 1 and 2, is the Latency associated transcript
(LAT), it is a non-coding RNA transcript that accumulates in the nuclei of neurons during latent
infection. US4 gene is unique to simplex viruses; it encodes glycoprotein G (gG) which is
significantly smaller (~1500 bp smaller) in HSV-1 compared to HSV-2 and has been used in
serological assays to differentiate between the two viruses. Other examples of genes unique to
simplex virus are; the US5 gene and US8.5 gene they encode glycoprotein J (gJ) which is
involved in preventing cytotoxic T-lymphocyte-induced apoptosis of infected cells, and a
phosphorylated protein that tends to localize in the nucleoli of infected cells, respectively. The
US12 gene encoding ICP47 interferes with MHC-I mediated antigen presentation in infected
cells. US 12 is another example of genes exclusively expressed by simplex viruses (Baines and
Pellett, 2007; Georgopoulou et al., 1995; Ghiasi et al., 1998; Jerome et al., 1999; Lee et al.,
1985; Roizman et al., 2007; York et al., 1994).
A few of viral gene products have been labeled as “non-essential” for viral replication in
vitro. These genes were labeled as such as experiments were performed on a single cell type or
in a narrow context of a particular condition of an experiment. Later, some of the proteins
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labeled as nonessential were proven to be essential in vivo and play important roles in infection
of various host cell types, neurotropism, latency, and evasion of host immune responses
(Nishiyama, 2004).
HSV-1 capsid
A mature herpesvirus genome is contained within a uniform and symmetric icosahedral
capsid which is approximately 15 nm thick, 1250 Angstrom in diameter and weighs 200 Mega
Dalton (MDa). The capsid is composed of 162 capsomeres that lie on a T-16 symmetrical
icosahedral frame. Five structural proteins form the building blocks of a capsid; VP5 (UL19),
VP26 (UL35), VP23 (UL18), VP19C (UL38), and the portal protein pUL6. These five structural
proteins and two additional proteins, pUL25 and pUL17, make up the C-capsid specific
components in mature DNA-filled capsids (Table 2.2). pUL26/26.5 are part of scaffold capsid
proteins that get lost when the DNA is packaged into the capsid. pUL26/26.5 is not present in
mature virions (Brown and Newcomb, 2011; Newcomb et al., 1999; Zhou et al., 2000).
Table 2.2: C-capsids structural protein composition. Adapted with modification from (Brown
and Newcomb, 2011).
Gene
UL19
UL38
UL18
UL35
UL6
UL17
UL25

Protein
VP5
VP19C
VP23
VP26
pUL6
pUL17
pUL25

Amino acids
1374
465
318
112
676
703
546
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Location in capsid
Hexons; pentons
Triplexes
Triplexes
Tip of hexon
Unique vertex
Near vertices
Near vertices

The 162 capsomeres are subdivided into 150 hexons, 12 pentons and 320 triplexes
(Figure 2.3). The hexons form the edges and faces of the icosahedral capsid; each hexon is
composed of 6 copies of VP5 and 6 copies of VP26. Each penton has 5 copies of VP5. Pentons
are located at capsid vertices and interact with UL36 tegument protein in mature virions. The
capsomeres are liked by a the triplexes which are composed of are composed of two copies of
VP23 and one copy of VP19C arranged as a heterodimer (Brown and Newcomb, 2011; Cardone
et al., 2012; Newcomb and Brown, 2010; Schmid et al., 2012; Zhou et al., 2000).

Figure 2.3: HSV-1 capsid structure. HSV-1 capsid with 12 pentons (red), 150 hexons (blue), and
320 triplexes (green). Image from (Zhou et al., 2000).
The capsid has 12 vertices; 11 of which are occupied by pentons. The 12th vertex is
occupied by a hollow cylindrical portal structure, 9 nm in length and 16.5 nm in outside
diameter with a ~3 nm diameter axial channel. This portal vertex is structurally composed of
twelve copies of pUL6 with 12-fold rotational symmetry. The portal vortex is thought to provide
the route for packaging and release of viral DNA. It may also play a role in docking of capsid to
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the nuclear pore complexes (NPCs). The portal vortex may potentially influence the spatial
arrangement of viral tegument and envelope as it has been shown to extend through the
tegument layer and possibly come in contact with the envelope (Brown and Newcomb, 2011;
Meyring-Wosten et al., 2014; Schmid et al., 2012).
Three morphologically distinct types of capsids (A, B, and C) can be observed by electron
microscopy in infected cells. A-capsids are empty as a result of failed DNA packaging process. Bcapsids also lack viral DNA, but contain scaffolding proteins. C-capsids are the type of capsids
that are ultimately found in mature infectious virions. They contain viral DNA and no scaffolding
protein. Also, C-capsids are distinguished by the presence of C-capsid specific components
(CCSCs) near capsid vertices (Figure 2.4).

Figure 2.4: The location of C-capsid specific components (CCSCs). CCSCs are highlighted in
green. Left panel shows a higher magnification of CCSCs in a single capsid vertex. Right, CCSCs
location is shown in the full capsid. Adapted and modified from (Brown and Newcomb, 2011).
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CCSCs are a rod shaped structure made up of one copy of pUL25 and one copy of pUL17.
It has been shown that CCSCs interface with the tegument by binding to the UL36 protein.
CCSCs is thought to fasten neighboring pentons against the internal pressure in DNA-loaded Ccapsids (Brown and Newcomb, 2011; Homa and Brown, 1997; Liu and Zhou, 2007).
HSV-1 tegument
The tegument is a proteinaceous matrix and a network layer that bridges the capsid and
the envelope. The tegument in mature virions consists of 24 proteins, including pUL7, pUL11,
pUL13, pUL14, pUL16, pUL21, pUL23, pUL36 (VP1/2), pUL37, pUL41, pUL46 (VP11/12), pUL47
(VP13/14), pUL48 (VP16), pUL49 (VP22), pUL50, pUL51, pUL55, pUS2, pUS3, pUS10, pUS11,
ICP34.5, ICP0 and ICP4 (Table 2.3). Four proteins, pUL46 (VP11/12), pUL47 (VP13/14), pUL48
(VP16) and pUL49 (VP22) are present in over a 1000 copy each and constitute the majority of
the tegument volume. By comparison, the tegument proteins pUL36 and pUL37 are present in
~120 copies per virion (Kelly et al., 2009; Newcomb and Brown, 2009). Tegument proteins;
pUL36 (VP1/2), pUL37, pUL48 and ICP4 are the only HSV-1 tegument proteins that are essential
for viral growth in cell culture (Kelly et al., 2009; Roizman et al., 2007).
Cryo-electron tomography imaging of mature HSV-1 virions shows the tegument as
asymmetrically distributed, dense granular layer interspersed with ~40 nm long and ~ 7 nm
wide filaments consistent with actin. At early time points in infected cells, the tegument tend to
be uniformly distributed around the capsid (Grunewald et al., 2003). As the virion particle
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matures over the course of approximately 40 hours, the tegument tends to congregate on one
side of the capsid, forming a cap-like structure and pushing the capsid off center (Grunewald et
al., 2003).
Tegument proteins are subdivided into inner and outer tegument proteins. Inner
tegument proteins consist of pUS3, pUL36 and pUL37 which remain associated with the capsid
after entry into the host cell. The remaining tegument proteins are categorized as outer
tegument proteins which detach from the capsid after entry into host cell. (Mettenleiter, 2006;
Newcomb and Brown, 2010).
Table 2.3: Tegument proteins and their function. Adapted and modified from (Kelly et al.,
2009).
Tegument protein

Predicted Mwt (kDa)

Functions

pUL7
pUL11
pUL13

33.1
10.5
57.2

pUL14

23.9

pUL16
pUL21

40.4
57.6

pUL23
pUL36 (VP1/2)

41.0
335.9

pUL37

120.6

pUL41

54.9

pUL46 (VP11/12)

78.2

pUL47 (VP13/14)

73.8

Regulates mitochondrial function
Secondary envelopment
Protein kinase, tegument dissociation, regulates
apoptosis and pUS3, inhibits IFN response
Nuclear import, regulates apoptosis, nuclear
targeting of capsids
Secondary envelopment
Secondary envelopment, regulates microtubule
assembly
Thymidine kinase, viral DNA replication
Capsid transport, secondary envelopment,
release of viral DNA, deubiquitinating activity
Secondary envelopment, regulates viral
transcription
Regulates host/viral translation and immune
response
Secondary envelopment, regulates pUL48dependent transcription
Secondary envelopment, regulates pUL48dependent transcription
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(Table 2.3 continued)
Tegument protein

Predicted Mwt (kDa)

Functions

pUL50
pUL51
pUL55
pUS2
pUS3

39.1
25.5
20.5
32.5
52.8

pUS10
pUS11
ICP34.5

34.1
17.8
26.2

ICP0
ICP4

78.5
132.8

dUTPase, viral DNA replication
Unknown
Unknown
Unknown
Protein kinase, primary deenvelopment,
tegument dissociation, regulates actin assembly
Unknown
Regulates host translation, capsid transport
Regulates host translation, viral DNA replication
and immune response
Regulates viral transcription
Regulates viral transcription

Tegument proteins play important roles not only as structural but also as functional
proteins (Table 2.3) (Kelly et al., 2009). UL36 protein (pUL36 or VP1/2) is a 3164 amino acid
protein encoded by the open reading frame UL36 (Roizman et al., 2007). The inner tegument
protein pUL36 have been shown to interact with capsid proteins VP5 and pUL25 and acts as the
link between the capsid and the outer tegument proteins (Bucks et al., 2011; Coller et al.,
2007). Also, pUL36 directly interacts with another inner tegument protein pUL37, which directly
interacts with the envelope proteins gK and pUL20, possibly providing a scaffold for the rest of
the tegument (Jambunathan et al., 2014; Mijatov et al., 2007; Newcomb and Brown, 2010). The
amino terminus of pUL36 contains a 420 aa ubiquitin-specific cysteine protease; this domain
with its active site at Cys65 deubiquitinates viral proteins to avoid degradation by the
proteasomal pathway (Kattenhorn et al., 2005). The amino terminus of VP1/2 also contains a
highly conserved functional nuclear localization signal (Abaitua and O'Hare, 2008). The
ubiquitin-specific cysteine protease domain of UL36 has been shown to down regulate IFN-Beta
production by deubiqitinating TNF receptor-associated factor 3 (TRAF3) (Wang et al., 2013).
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pUL36 along with other inner tegument proteins (pUL37 and pUS3) also recruits the motor
molecule dynein and its cofactor dynactin during retrograde transport (Radtke et al., 2010).
UL36 protein plays a role in DNA packaging and release form the capsid.
The HSV-1 UL37 gene encodes a 120.6 kD, 1123 aa protein that encompasses a variety
of functional domains (Figure 2.5). UL37 protein is essential for viral assembly, secondary
envelopment in the cytoplasm and regulation of viral transcription (Bucks et al., 2011; Kelly et
al., 2009; Mettenleiter, 2002). The amino terminus of UL37 contains a self association domain
(in the absence of UL36), and leucine-rich nuclear export signal (NES)(Bucks et al., 2011;
Watanabe et al., 2000). The fuction of the central domain of UL37 is yet unclear. The carboxy
terminus of UL37 contains a motif that activates NF-kB signaling by binding TNF receptorassociated factor 6 (TRAF6). Modulation of Nf-kB activity possibly affect the transcriptional
activation of viral intermediate early genes such as ICP0 (Amici et al., 2006; Bucks et al., 2011;
Liu et al., 2008). The domain spanning residues 578-899 of the carboxyl terminus of UL37 have
also been shown to interact with a cytoskeletal cross-linker called dystonin/BPAG1 which is
involved in microtubule stabilization and transport (Pasdeloup et al., 2013). The pUL36 and
pUL37 are highly conserved among all Herpesviruses which highlight their importance as
structural as well as functional viral proteins (Mettenleiter, 2002).
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Figure 2.5: Functional domains of the UL37 protein. Adapted with modification from
(Jambunathan et al., 2014).
US3 and UL13 proteins are versatile viral serine/threonine protein kinases. They
contribute along with cellular kinases, to the phosphorylation of other tegument proteins prior
to their dissociation from the capsid during entry (Asai et al., 2007; Kato et al., 2005; Kelly et al.,
2009). US3 has an anti-apoptotic activity through phosphorylation of pro-apoptotic Bcl-2 family
members. By contrast, pUL13 has a pro-apoptotic activity (Benetti and Roizman, 2007;
Hagglund et al., 2002; Jerome et al., 1999; Kelly et al., 2009).
The UL41 gene encodes the 54.9 kD outer tegument protein known as virion host
shutoff (vhs) protein. Vhs dissociates from the virion capsid during entry and functions as an
endoribonuclease RNase A to degrade mRNA resulting in shutting down the host cell gene
expression as well as viral protein synthesis. Viral mRNAs though, are rescued by VP16; at a
later stage of infection pUL48 (VP16) interacts with pUL41 to inhibit pUL41 activity and
facilitate its incorporation into virion particles. (Lam et al., 1996; Taddeo and Roizman, 2006).
VP16, also referred to as (α-transinducing factor (α-TIF), is an outer tegument protein
that is required for initiation of transcription of viral alpha genes such as ICP0 and ICP4 in a lytic
infection (Campbell et al., 1984; Kelly et al., 2009; Roizman et al., 2007).
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ICP0 protein is encoded by the RL2 gene form the reiterated sequences region. ICP0
protein is a 775- aa promiscuous transactivator of genes (Kelly et al., 2009; Roizman et al.,
2007). It contains a RING finger domain and ubiquitin ligase E3 domain (Roizman et al., 2007).
The expression of ICP0 protein directly depends on pUL48 as discussed above. The efficiency of
ICP0 functions are enhanced by its interaction with ICP4. The two major functions of ICP0 are;
to facilitate the transition from α to β viral-gene expression and to block the inhibition of viral
gene expression by host cell interferons through its ubiquitin ligase activity (Gu and Roizman,
2007; Harle et al., 2002).
The tegument is an important structural and functional component of the virion
particle. It accounts for approximately 40% of the total virion protein mass and two-thirds of
the virion particle volume (Grunewald et al., 2003; Liu and Zhou, 2007).
HSV-1 envelope
The envelope is a host-derived lipid bilayer outer covering of the virus. Herpes Simplex
Virus envelope contains at least 12 different glycoproteins and several other non-glycosylated
membrane-associated viral proteins. The glycoproteins include pUL1 (gL), pUL10 (gM), pUL22
(gH), pUL27 (gB), pUL44 (gC), pUL49.5 (gN), pUL53 (gK), pUS4 (gG), pUS5 (gJ), pUS6 (gD), pUS7
(gI) and pUS8 (gE). The non-glycosylated membrane proteins include pUL20, pUL24, pUL43,
pUL45, pUL56 56 and pUS9 (Campadelli-Fiume and Menotti, 2007; Roizman et al., 2007).
Although pUL34 is not present in the envelope of extracellular virions, it mediates primary
envelopment in concert with pUL31 (Roizman et al., 2007).
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Cryo-electron tomography of HSV envelope reveals that the envelope is approximately 5
nm thick with 600-750 non-randomly clustered glycoprotein spikes of highly variable length,
spacing and morphology embedded in the viral envelope (Figure 2.6) (Grunewald et al., 2003).
In these tomography images, the glycoprotein spikes appears to be clustered in the
areas were the tegument is dense, in support of the documented experimental evidence of the
interaction between HSV-1 tegument proteins and envelope glycoproteins (Grunewald et al.,
2003). It has been shown, using mutational analysis and biochemical approaches that the
cytoplasmic portions of gB, gD and gH bind to the outer tegument protein VP16 (pUL48)(Gross
et al., 2003; Kamen et al., 2005; Zhu and Courtney, 1994). Also, the interactions between the
cytoplasmic tails of gD and gE and the tegument proteins pUL11 and pUL49 (VP22) have been
demonstrated by co-immunoprecipitation experiments (Chi et al., 2005; Farnsworth et al.,
2007a; O'Regan et al., 2007). In PRV, UL49 physically interacts with the cytoplasmic domains of
the membrane protein US9 and the carboxyl terminus of gE/gI and gM (Fuchs et al., 2002a; Lee
et al., 2008). Most recently, the interaction between the membrane proteins gK and pUL20 and
pUL37 have been reported using co-immunoprecipitation experiments and proximity ligation
assays (Jambunathan et al., 2014).
Viral membrane proteins play important roles in viral life cycle and in the interaction
between the virus and the host. Various glycoproteins participate in virion attachment and
entry through interacting with host cell receptors. Membrane proteins also play crucial roles
during egress and envelopment as well as infectious virus production via interactions with the
tegument (Roizman et al., 2007).

31

Figure 2.6: Three- dimensional tomographic reconstruction of HSV-1 virions after denoising. (A)
Glycoprotein spikes in yellow are protruding from the membrane colored in blue. (B) Virion
interior, the capsid is shown in light blue and the tegument “cap” (orange) inside the envelope
(blue and yellow). pp, proximal pole; dp, distal pole. Scale bar, 100 nm. Adapted from
(Grunewald et al., 2003).
Viral membrane proteins play important roles in viral life cycle and in the interaction
between the virus and the host. Various glycoproteins participate in virion attachment and
entry through interacting with host cell receptors. Membrane proteins also play crucial roles
during egress and envelopment as well as infectious virus production via interactions with the
tegument (Roizman et al., 2007).
Glycoprotein B. Glycoprotein B is a 904 amino acid glycosylated transmembrane
glycoprotein encoded by the gene UL27. gB is the most conserved component of the fusion
machinery of herpes viruses. The extracellular portion (ectodomain) of gB is the largest domain
composed of 696 aa with multiple N-glycosylation sites. The crystal structure of the gB
ectodomain reflects features similar to both class I and class II fusion proteins with a striking
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homology to glycoprotein G from vesicular stomatitis virus (VSV G). gB possesses an alphahelical coil-coil core that relates it to class I fusion proteins and an extended beta hairpin with
hydrophobic tips that relates gB to class II fusion proteins. The gB fusogenic activity is
accomplished through a large scale conformational change of "open" and "closed" or folding
and unfolding rearrangements of the trimetric gB complex (Figure 2.7)(Heldwein et al., 2006).
gB is one of four glycoproteins known as the fusion complex (gD, gH, gL, and gB). The
interactions between gD and the gH/gL heterodimer with gB presumably trigger conformational
rearrangements in gB to initiate fusion. It has also been shown that gB binds to cellular
receptors such as the myelin-associated glycoprotein (MAG) paired immunoglobulin-like type-2
receptor alpha (PILR-alpha), and non-muscle myosin heavy chain IIA (NMHC-IIA) which may also
assist in triggering the gB conformational changes necessary for fusion (Chowdhury et al., 2012;
Connolly et al., 2011) (Arii et al., 2010), (Satoh et al., 2008; Suenaga et al., 2010). Moreover,
accessory proteins such as gK and UL20 may also be required for optimal fusion process. It has
been reported that the direct interaction of gB with gK and UL20 modulates gB-mediated cell
fusion (Chouljenko et al., 2010; Foster et al., 2004; Melancon et al., 2005).

33

Figure 2.7: Schematic diagram of gB, showing conformational refolding between a “closed” (A)
and “open” (B) state in an umbrellalike fashion. gB Domains are shown schematically in
different colors. Adapted from (Heldwein et al., 2006).
In addition to its role in virus induced cell fusion during entry, gB has been shown to
bind to Toll Like Receptor 2 /Toll-like Receptor 6 heterodimer leading to MyD 88 mediated
activation of NF-kB (Cai et al., 2013).
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Glycoprotein K. gK is a 338 aa glycosylated HSV-1 envelope protein that is encoded by
UL53 gene. gK is highly conserved among all alphaherpesviruses. The secondary structure of gK
is composed of an amino terminus and a carboxyl terminus both located extracellularly, four
membrane spanning domains and small cytoplasmic domains. The amino terminus of gK
contains a 30 aa signal sequence and two N-linked glycosylation sites at residues 48 and 58
(Figure 2.8; gK secondary structure)(Foster et al., 2003; Ramaswamy and Holland, 1992).

Figure 2.8: Schematic representation of the secondary structure of gK. The 30 amino acid signal
peptide is shown in red. The four transmembrane domains are shown in yellow.
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Several single amino acid mutations in gK, primarily in the amino terminus, have been
shown to cause syncytia formation in tissue culture (Pogue-Geile et al., 1984; Ruyechan et al.,
1979). gK forms a heterodimer with the non-glycosylated membrane protein UL20. The
interaction between gK and UL20 is important for the transport of the protein complex (gKUL20 heterodimer) through the Golgi network (Foster et al., 2008; Melancon et al., 2007). gK
plays a critical role in the cytoplasmic virion envelopment and infectious virus production. gK
deletion mutants accumulate in the cytoplasm as un-enveloped virions and are unable to egress
from infected cells (Foster and Kousoulas, 1999; Hutchinson et al., 1992; Hutchinson and
Johnson, 1995; Jayachandra et al., 1997; Ramaswamy and Holland, 1992). The role of gK in
virus-induced cell fusion was studied, using a variety of deletion, truncation and syncytial
mutants of gK. Work in Dr. Kousoulas’ laboratory demonstrated that the amino terminus of gK
physically interacts with the amino terminus of gB and modulates gB mediated virus induced
cell fusion (Chouljenko et al., 2009; Chouljenko et al., 2010). Also, cleavage of the amino
terminus of HSV-1 gK significantly reduced virus entry (Jambunathan et al., 2011). The amino
terminus of gK is also required for efficient entry into Chinese Hamster Ovary cells (CHO cells)
expressing

the

gB

receptor;

paired

immunoglobulin-like

type-2

receptor

alpha

(PILRα)(Chowdhury et al., 2013). gK overexpression was correlated with the accumulation of
large numbers of virion particles in the perinuclear space (Hutchinson and Johnson, 1995).
Mutant viruses lacking the expression of both gB and gK or gB and UL20 accumulated capsids in
the cytoplasm suggesting that pUL20, gK and gB do not function redundantly in the deenvelopment process at the outer nuclear membrane (Melancon et al., 2005).

36

In addition to gK roles in; virus-induced cell fusion, envelopment and virion egress, it
plays important roles in neuroinvasion and ocular pathogenesis (David et al., 2008; David et al.,
2012). Further experiments to delineate gK domains that are important for neuroinvasion have
demonstrated that the amino terminus of gK, however dispensable for replication in tissue
culture, is important for neuroinvasion and the pathogenesis of keratitis (David et al., 2012; Kim
et al., 2014; Saied et al., 2014). It has been shown that the signal peptide of gK contains a T cell
epitope, however, since the signal peptide is cleaved, its significance in immunomodulation is
yet to be determined (Osorio et al., 2007).

I collaborated with Misagh Naderi and Dr. Michal Brylinski at the Computational
Systems Biology group, Louisiana State University to generate a predicted tertiary (folded)
structure for gK (Figure 2.9) and UL20 protein. gK was modeled based on validated templates.
The predicted structure showed that the transmembrane domains are alpha helices, the amino
terminus of gK is composed of beta sheets and short alpha helices, and domain II folds into two
connected alpha helices. The predicted folding of domain II into alpha helices suggests that this
domain may have an important function, which is open for investigation. The gK tertiary
structure prediction is still in progress as we are still addressing some important factors that, if
considered in the model, may alter the predicted tertiary structure of gK.
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Figure 2.9: The predicted tertiary structure of gK. The amino terminus in blue (dark and light),
the last transmembrane domain and the carboxyl terminus are in red. Domain III is predicted to
have two connected alpha helices.
Glycoprotein M. Glycoprotein M (gM) is a 473 aa, highly conserved type III integral
membrane protein encoded by UL10 gene. gM forms a functional complex with pUL49.5 (gN).
The structure of gM (Figure 2.10) is composed of amino terminus cytoplasmic domain that
contains 2 initiation codons, 8 membrane spanning domains, 2 N-glycosylation sites in
extracellular domains, and a carboxyl terminal cytoplasmic domain that contains 4 tyrosinebased endocytosis motifs (YXXΦ; YDEV426, YAKI438, YDTV454 and YSTV470)(Baines and
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Roizman, 1993; Crump et al., 2004; Roizman et al., 2007). Deletion UL10 gene does not abolish
HSV-1 replication, but reduces the ability of the virus to spread from cell to cell in tissue culture
(Browne et al., 2004; Chouljenko et al., 2012; Leege et al., 2009; MacLean et al., 1993).
Glycoprotein M mutant viruses showed alterations in several viral membrane proteins
localization patterns in the trans-Golgi network (TGN); which implies that gM may function in
retention or retrieval of viral glycoproteins in or form the trans-Golgi network (TGN)(Crump et
al., 2004; Klupp et al., 2000; Leege et al., 2009).
The syncytial phenotype caused by mutation in the carboxyl terminus of gB [A855V
(gBsyn) and gBΔ28] was inhibited by deletion of gM in these syncytia-forming viruses. Also,
recombinant viruses lacking gM had slower entry kinetics in Vero cells (Balan et al., 1994; DavisPoynter et al., 1994; Kim et al., 2013). Work in this laboratory showed that deletion of gM and
the

membrane
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membrane
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events.
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co-

immunoprecipitation experiments have detected an interaction between gM and UL20 (Kim et
al., 2013).
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Figure 2.10: A schematic diagram of the predicted secondary structure of HSV-1 gM. The yellow
box indicates plasma membrane. Two initiation methionines (empty arrows) and two potential
N-glycosylation sites (black solid arrows), C-terminal tyrosine-based endocytosis motifs are
indicated by blue boxes. The dark and light green boxes indicate alpha helices. [Structure built
by SOSUI prediction (Hirokawa et al., 1998)].

UL 20 protein (pUL20). UL20 protein is 222 aa non-glycosylated membrane protein that
is conserved in all alphaherpesviruses. The predicted secondary structure of pUL20 is composed
of five domains; the amino terminus (Domain I) and the carboxyl terminus (Domain V) are
located within the cytoplasm, 4 transmembrane domains and Domains II and IV located
extracellularly (Figure 2.11).
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Figure 2.11: The predicted secondary structure of the UL20 protein. The protein is composed of
four transmembrane domains and five predicted regions are shown. Adapted with permission
from PhD dissertation titled “The Role of Viral Glycoproteins and Tegument Proteins in Herpes
Simplex Virus Type 1 Cytoplasmic Virion Envelopment” by Dmitry V. Chouljenko, Louisiana State
University, School of Veterinary Medicine, Department of Pathobiological Sciences, August
2014.

pUL20 forms a heterodimer with gK. The interaction between gK and UL20 is important
for the transport of the protein complex (gK-UL20 heterodimer) through the golgi network
(Foster et al., 2008; Melancon et al., 2007). This gK/pUL20 complex functions in virion
envelopment, egress, and virus-induced cell fusion. pUL20 functional domains play
independent roles in virus-induced cell fusion and cytoplasmic virion envelopment; mutations
in tyrosine residues in the amino terminus of pUL20 compromised infectious virus production
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and virus induced cell fusion, however, allowed efficient intracellular transport and TGN
localization of UL20p and gK (Melancon et al., 2004; Melancon et al., 2007). Most recently,
work in this laboratory showed that phenylalanine residues at the carboxyl terminus of pUL20
play crucial roles in viral cytoplasmic envelopment and infectious virion production.
Interestingly, replacement of phenylalanine-to-alanine at amino acid position 210 in the
carboxyl terminus of pUL20 caused a gain-of-function phenotype (Charles et al., 2014).
Life Cycle of Herpes Simplex Virus Type 1
Infection with HSV-1 starts at the mucocutaneous membranes where the virus
replicates and then infects axonal endings and transports in retrograde manner to the body of
the neuron in the trigeminal ganglia to establish latent infection. Exposure to UV light or
stressors leads to reactivation of the virus whereby virions transport in anterograde manner to
the primary site of infection for lytic replication and viral shedding.
Infection of epithelial cells at the primary site of infection is a multistep involving virus
entry, transport of capsids to the nucleus, viral gene expression and DNA replication, capsid
assembly, primary envelopment, secondary envelopment, and egress and maturation of
infectious virions. During entry, viral glycoproteins interact with cell surface receptors for the
attachment, binding and fusion between viral envelope and the cell membrane. After entry, the
virus sheds the envelope at the surface and the capsid and the associated inner tegument
proteins travel to the nucleus, dock at the nuclear pore complex and deposit viral DNA to the
nucleus leading to the start of another viral replication cycle. In the nucleus of neurons,
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however, the virus establishes latency for the life of the host. During latency, viral DNA
associates with nucleosomes in a circular episome form, and the Latency Associated Transcript
(LAT) is produced. Assembly of capsids and packaging of DNA take place in the nucleus.
In a process called primary envelopment, nucleocapsids travel to the cytoplasm by
moving across the nuclear membrane. In the cytoplasm, tegument proteins are assembled on
the nucleocapsid. The interaction between tegument proteins and viral envelope proteinenriched TGN-derived vesicles facilitates acquiring the envelope in a process known as
secondary envelopment. Enveloped virions enclosed inside the vesicles transport to plasma
membrane to release virions into the extracellular environment (Figure 2.12) (Bastian et al.,
1972; Roizman et al., 2007; Vittone et al., 2005).
Viral attachment, binding and entry
Mature infectious virion particles initiate the infection by virion attachment to the
cellular receptors. This attachment step is mediated by binding of the amino terminus
glycoprotein C (gC) to cell surface receptors such as heparan sulfate and chondroitin sulfate
glycosaminoglycans (GAGs)(Campadelli-Fiume and Menotti, 2007; Herold et al., 1991; Roizman
et al., 2007; Tal-Singer et al., 1995; WuDunn and Spear, 1989). It has also been shown that gB
participates in the attachment step by binding to GAGs on cell surfaces(Laquerre et al., 1998).
The ability of gB to mediate the attachment may explain the observation that deletion of gC
does not impair viral attachment(Griffiths et al., 1998). Interestingly, deletion of heparan
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sulfate and chondroitin sulfate glycosaminoglycans (GAGs) significantly reduces viral infectivity
but does not completely abolish infection from taking place (Gruenheid et al., 1993). The
attachment step is revisable and does not require energy(Campadelli-Fiume and Menotti,
2007).

Figure 2.12: Schematic diagram of Alphaherpesviruses life cycle. Electron micrographs of the
respective stages are shown. (1) Attachment. (2) Penetration. (3) Transport of the capsid to the
nucleus (N). (4) Interaction of nucleocapsid with microtubules (MT). (5) Docking at the nuclear
pore (NP). (6) Release of viral genome into the nucleus. Here, transcription of viral genes and
genome replication takes place. (7) Assembly of Capsids. (8) Encapsidation of viral genome into
preformed capsids. (9) Newly formed nucleocapsids leave the nucleus by budding at the Inner
Nuclear Membrane (INM). (10) Virions located in the perinuclear space fuse (11) with the outer
nuclear membrane. (12) Intracytosolic capsids bud into vesicles of the Trans-Golgi Network
(TGN) in a step called secondary envelopment. After transport to the cell surface (13), (14)
vesicle and plasma fuse to release mature virions to the extracellular space. Adapted from
(Mettenleiter et al., 2009).
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Typically, herpes simplex viruses enter cells via fusion of the viral envelope with plasma
membranes; however, it can enter a wide range of cells via either pH independent or pHdependent endocytosis (Milne et al., 2005; Nicola et al., 2003). The entry step is mainly
mediated by the interaction between the ectodomain of Glycoprotein D (gD) with cellular
receptors. The transmembrane and cytoplasmic domains of gD do not seem to play a role in
viral entry, however, they serve to anchor gD to the viral envelope (Browne et al., 2003).
Cellular receptors for gD include members of tumor necrosis factor receptor family
(TNF) such as herpes virus entry mediator A (HVEM or HveA). This family of cellular receptors is
expressed on many mammalian epithelial cells, fibroblasts as well as cells of the immune
system such as B and T lymphocytes and monocytes, however, neurons do not express this
family of receptors (Kwon et al., 1997; Spear, 2004). Members of immunoglobulin superfamily
also serve as receptors for gD; examples include nectin-1, nectin-2, paired immunoglobulin-like
type 2 receptor alpha (PILR-2 alpha) and 3-O sulfated heparan sulfates. Nectin 1 alpha and beta
are expressed on neuronal cells as wells as epithelial cells fibroblasts and hematopoietic cells
(Cocchi et al., 1998a; Cocchi et al., 1998b; Geraghty et al., 1998). Binding of gD to its cognate
receptor triggers conformational changes in gB, gH, and gL which leads to the fusion of viral
envelope with cell membrane (Campadelli-Fiume and Menotti, 2007; Cocchi et al., 2004;
Roizman et al., 2007). 3-O-sulfated heparan sulfate is expressed in neurons as well as a variety
of other tissues and serves as a receptor for the ectodomain of gD(Campadelli-Fiume and
Menotti, 2007).
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Fusion activity in HSV is executed by a multipartite fusion complex composed of gB and
the gH/gL heterodimer. The presence of this fusion machinery is absolutely required for fusion
to proceed (Cai et al., 1988; Campadelli-Fiume and Menotti, 2007; Forrester et al., 1992; Roop
et al., 1993). gL is necessary for incorporation of gH in the virion particle and its absence
abrogates entry(Roop et al., 1993). It has been shown that gB binds to a variety of cellular
receptors including the paired immunoglobulin-like type-2 receptor alpha (PILR-α), myelinassociated glycoprotein (MAG) and non-muscle myosin heavy chain IIA (NMHC-IIA), however,
the importance of this binding in the fusion process is yet to be determined(Arii et al., 2010;
Chowdhury et al., 2012; Satoh et al., 2008; Suenaga et al., 2010).
The fusogenic activity of gB is regulated by accessory proteins. Work in this laboratory
has shown that gK and UL20 directly interact with gB and modulate its function in virus induced
cell fusion. gM may indirectly participate in optimal gB fusigenic activity through interaction
with pUL20 (Chouljenko et al., 2010; Foster et al., 2004; Kim et al., 2013; Melancon et al., 2005).
Transport of capsids to the nucleus
Upon fusion, the viral envelope is shed at the cell membrane and the nucleocapsids and
tegument proteins are deposited in the cytosol. The outer tegument proteins such as pUL41,
pUL47 and pUL48 (VP16) then dissociate from the nucleocapsid and the associated inner
tegument proteins (Liu et al., 2010; Mettenleiter, 2006). pUL41, also known as the Virion Host
Shutoff protein (VHS) inhibits the production of host proteins by inhibiting host mRNA synthesis
and processing, and by speeding mRNA degradation. VHS targets both host and viral mRNAs,
however, at late stages of infection viral mRNAs are rescued by VP16; which interacts with
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pUL41 to inhibit its activity and to facilitate its incorporation into virion particles(Everly et al.,
2002; Lam et al., 1996; Roizman et al., 2007; Taddeo and Roizman, 2006). VP16 (pUL48), also
known as alpha trans-inducing factor (αTIF) travels to the nucleus, forms a complex with the
cellular protein Oct-1 and initiates the transcription of viral immediate early genes (Newcomb
and Brown, 2009). Nucleocapsids and the associated inner tegument proteins are propelled
along microtubules to the nucleus (retrograde transport) via the cellular motor molecules
complex called Dynine. Anterograde transport from the nucleus to the plasma membrane is
mediated by the Kinesin motor molecule (Diefenbach et al., 2008; Garner, 2003; Sodeik et al.,
1997). Inner tegument proteins pUL36, pUL37 and US3 remain in the capsid and their presence
is required to recruit cellular transport motor molecules (Sodeik et al., 1997). After transport,
capsids dock onto the nuclear pore complex and the viral DNA is extruded from the capsid into
the nucleus (Figure 2-13). pUL36 plays an important role in DNA deposition into the nucleus
through its interaction with the nuclear pore complex proteins(Batterson et al., 1983; Batterson
and Roizman, 1983; Ojala et al., 2000; Sodeik et al., 1997). pUL36 acts as a plug to keep viral
DNA packaged in the capsid. Cleavage of pUL36 is necessary to release viral DNA into the cell
nucleus (Jovasevic et al., 2008). pUL25 is also involved in the release of viral genome into the
nucleous; pUL25 interacts with nucleoporins CAN/Nup214 and hCG1. pUL25 also binds to the
portal protein pUL6 and pUL36 (Jovasevic et al., 2008).
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Figure 2.13: A colored electron micrograph of HSV-1 capsid at the nuclear pore complex (NPC).
The figure shows an empty capsid shortly after deposition of viral DNA through the NPC.
Adapted from (Bauer et al., 2013).

Viral gene expression and DNA replication
After deposition of viral genome in the nucleus, viral DNA circularizes forming endless
genomes. It has been shown that cellular DNA ligase IV and the DNA repair protein XRCC4 are
required for the formation of circular viral genomes during productive infection (Muylaert and
Elias, 2007; Strang and Stow, 2005). Production of viral proteins can be classified based on the
temporal gene expression into; immediate early genes or alpha gene expression, early genes or
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Beta gene expression, and late genes or Gamma gene expression (Roizman et al., 2007). As
discussed before, VP16 (alpha-TIF) dissociates from the tegument once in the cytoplasm, binds
to host C1 and the complex then enters the nucleus and binds to Oct-1(Katan et al., 1990;
Kristie and Sharp, 1990). This tripartite complex initiates the transcription of viral immediate
early genes (alpha genes) (Newcomb and Brown, 2009). Alpha genes; ICP0, ICP4, ICP22, ICP27,
ICP47 and pUS1.5 are expressed immediately after infection and their products peak at 2-4
hours post infection. In general, alpha gene products are required for the activation of the
expression of beta genes. ICP0 stimulates expression of all classes of viral genes (Everett, 2000).
ICP4 is required for transcription of early and late gene promoters(Everett, 2000). Expression of
beta genes peaks at 4-8 hours after infection. Beta gene products function in viral DNA
replication process and gamma gene expression. Examples of beta gene products include;
ribonucleotide reductase, thymidine kinase, viral DNA polymerase (UL30), DNA binding proteins
(UL42 and UL29 or ICP8), ORI binding protein (UL9), and the helicase/primase complex (UL5, 8,
and 52)(Muylaert et al., 2011; Roizman and Campadelli-Fiume, 2007). Gamma genes include
structural viral proteins, tegument and glycoproteins and their gene expression peaks after viral
DNA replication process has started. Gamma genes are divided into gamma 1 and gamma 2
genes based on their temporal expression. Gamma 1 gene expression starts earlier sometimes
as early as alpha genes (known as leaky genes), and gamma 2 genes are expressed only after
DNA replication has begun. An example of gamma 2 genes include gK (Roizman and CampadelliFiume, 2007). During viral replication, the origin-binding protein pUL9 facilitates loading of the
viral replisome complex on viral genome origins of replication. Viral replisome complex is
composed of the viral DNA polymerase (pUL30 and pUL42), a helicase-primase (pUL5, pUL8 and
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pUL52), and the single-stranded DNA-binding protein pUL29 (ICP8)(Muylaert et al., 2011). Viral
DNA replication uses a rolling circle mechanism and the newly formed viral genomes are
produced. Host RNA polymerase II handles viral RNA transcription using the newly synthesized
viral DNA as a template (Costanzo et al., 1977; Muylaert et al., 2011). In neurons, the virus
establishes a latent infection where the productive lytic sequence of gene expression does not
occur. Instead, viral genome remains in the nucleus in an episomal form and the non coding
RNA latency associated transcript (LAT) accumolates in the nuclei of nurones. LAT silences other
viral genes and protects nurones form apoptosis (Perng et al., 2000).
Capsid assembly and DNA packaging
Viral proteins are synthesized in the cytoplasm of infected cells. The structural
components of the capsid are then imported to the nucleus for assembly. The overlapping UL26
and UL26.5 gene products are cleaved to produce the scaffolding proteins VP21 and VP22a.
UL26.5 also produces VP24 which is a protease that cleaves viral capsid scaffold proteins. Two
copies of VP19C and one copy of VP23 form a complex in the cytoplasm and transport together
into the nucleus. Within the viral nuclear inclusion bodies, the major capsid protein VP5 binds
to the scaffolding proteins VP21 and VP22a forming 125 nm spherical pro-capsids as hexones,
pentons and triplexes are assembled(Brown and Newcomb, 2011; Nicholson et al., 1994; Rixon
et al., 1996; Roizman et al., 2007). DNA packaging into the capsid occurs through the portal
(composed of 12 copies of pUL6). The viral terminase complex composed of pUL15, pUL28 and
pUL33 aids in viral DNA packaging by cleaving the viral DNA concatomers into monomers.
Maturation of capsid takes place as VP24 (protease) cleaves the scaffolds and the capsid starts
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to assume mature polyhedral shape(Brown and Newcomb, 2011). As the capsid angularizes,
VP26 assembles on the maturing capsid in an energy dependent manner(Chi and Wilson, 2000).
After that, pUL36 is recruited at the portal to serve as plug keeping the viral DNA securely
contained within the capsid(Jovasevic et al., 2008).
Primary envelopment
The relatively small nuclear pore (~39 nm) does not allow the passage of the 125 nm
diameter of the viral capsid to the cytoplasm. The relatively large capsids bud into the inner
nuclear membrane forming enveloped capsids in the peri-nuclear space, then the enveloped
capsids undergo de-envelopment at the outer nuclear membrane to exit into the cytoplasm.
This model is known as the envelopment and de-envelopment pathway (Hofemeister and
O'Hare, 2008; Johnson and Baines, 2011).
Acquisition of an envelope at the inner nuclear membrane is mediate by pUL31 and
pUL34. pUL34 is a virus-encoded membrane anchored protein present at the inner nuclear
lamina and forms a heterodimer with pUL31(Shiba et al., 2000). The pUL34/pUL31 complex,
also known as the nuclear egress complex (NEC), recruits viral and cellular kinases to
phosphorylate and soften the nuclear lamina (Mettenleiter et al., 2013; Reynolds et al., 2001;
Roller et al., 2000). The NEC recruits cellular kinases such as protein kinase C alpha and C delta
to phosphorylate lamin B, whereas, lamin A and lamin C are phosphorylated by the viral kinases
pUS3 and pUL13. Phosphorylation of lamins disrupts and dissolves the nuclear lamina allowing
the interaction of nucleocapsids with the inner nuclear membrane (Mettenleiter et al., 2013;
Mou et al., 2007; Park and Baines, 2006). C-capsids (DNA-containing capsids) are preferentially
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selected for the primary envelopment process. UL31 protein favorably binds to pUL25
component of the C-capsid specific (CCSCs) at capsid vertices. It can also interact with the
pUL17 CCSC component in the absence of pUL25 (Yang et al., 2014). Both pUL31 and pUL34
have been detected in virions present in the perinuclear space. Interestingly however, mature
virions do not contain pUL31 and pUL34 (Fuchs et al., 2002b).
Nucleocapsids with a primary envelope are already coated with a thin layer of tegument
proteins, and the rest of tegument proteins will be added before or during secondary
envelopment (Mettenleiter, 2002; Mettenleiter et al., 2009; Padula et al., 2009). In a process
called de-envelopment, the enveloped nucleocapsids in the perinuclear space fuse with the
outer nuclear membrane to exit to the cytoplasm. The core fusion machinery gB and gH/gL
which is involved in virion fusion during entry also mediates the de-envelopment process.
Deletion of gB and gH leads to accumulation of enveloped virions in the peri-nuclear space
(Farnsworth et al., 2007b; Wright et al., 2009). Furthermore, phosphorylation of gB by the viral
kinase pUS3 promotes the fusion of enveloped nucleocapsids with the outer nuclear membrane
(Wisner et al., 2009).
Secondary envelopment
Nucleocapsids released into the cytoplasm acquire more tegument as they travel to the
site of secondary envelopment at trans-Golgi network (TGN) derived vesicles and endosomes.
Already covered with a thin layer of tegument, capsids get coated with more pUL36 and pUL37
tegument proteins. Nucleocapsids are propelled along microtubules to the sites of secondary
envelopment at the TGN as a result of the interaction between pUL36 and pUL37 tegument
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proteins and the cellular motor molecule Kinesin. Also, the presence of pUL36 and pUL37 is
required for the successful incorporation of other tegument proteins (Luxton et al., 2006;
Sandbaumhuter et al., 2013).
Additional tegument proteins are added to the capsid during the secondary
envelopment; tegument proteins bind to the cytoplasmic surface of TGN membranes and as
the capsids bud into TGN derived vesicles they acquire envelops (Johnson and Baines, 2011).
After expressed in the cytoplasm, viral envelope proteins are sorted to the TGN
membranes where the carboxyl termini facing towards the cytoplasm. Viral glycoproteins are
subjected to modifications by mannose-6-phosphate (M6P), and they contain a variety of
sorting domains, including di-leucine motifs, tyrosine motifs and acidic clusters, similar to those
found on host TGN proteins. The above mentions modifications and the presence of sorting
domains facilitate sorting of viral glycoproteins such as gB, gD, gE/gI to TGN (Beitia Ortiz de
Zarate et al., 2004; Gu et al., 2001; McMillan and Johnson, 2001).
A complex network of interactions between the capsid and tegument proteins, and the
carboxyl termini of envelope glycoproteins facilitate secondary envelopment (Figure 2.14).
The inner tegument protein pUL36 have been shown to interact with capsid proteins
VP5 and pUL25 and acts as the link between the capsid and the outer tegument proteins (Bucks
et al., 2011; Coller et al., 2007). Also, pUL36 and pUL37 interact with pUL48 andpUL46,
respectively. pUL48, an outer tegument protein, interacts with the tegument proteins pUL41,
pUL46, pUL47 and pUL49 (Elliott et al., 1995; Newcomb and Brown, 2009; Smibert et al., 1994;
Vittone et al., 2005). pUL21 and pUL16 form a complex; this interaction has been documented
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in HSV-1 and PRV (Klupp et al., 2005). pUL16 also interacts with the membrane-associated
tegument protein UL11(Loomis et al., 2003; Yeh et al., 2008). pUL11 in turn, interacts with gD
and gE serving as a bridge between the tegument covered capsid and the envelope to facilitate
secondary envelopment(Farnsworth et al., 2007a; Meckes et al., 2010; Yeh et al., 2008). The
cytoplasmic domains of gE and gD and gM interact with pUL49 (VP22) which presence is
important for the incorporation of gD, gE/gI and ICP0 into virions (Stylianou et al., 2009) (Chi et
al., 2005; Farnsworth et al., 2007a; O'Regan et al., 2007). Interestingly, absence of pUL49 (VP22)
does not affect the incorporation of ICP4, the binding partner of ICP0, in virion particles (Duffy
et al., 2006; Elliott et al., 2005; Yao and Schaffer, 1994). Recruitment of VP22 into virion
particles is also dependent on its interaction with the cytoplasmic tail of gE(Stylianou et al.,
2009). The interaction between pUL48 and the cytoplasmic portions of gB, gD and gH has been
documented using chemical cross-linking assays and protein pull-down experiments (Foster and
Kousoulas, 1999; Kamen et al., 2005; Zhu and Courtney, 1994). In addition to phosphorylation
of nuclear lamina, pUL13 phosphorylates both gE and pUL49 and modulates pUL41 function
(Coulter et al., 1993; Ng et al., 1998; Overton et al., 1994).
Another complex network of interactions between viral membrane and the inner
tegument has been reported. Proximity ligation assay and co-immunoprecipitation experiments
showed that the inner tegument protein UL37 binds to the membrane proteins pUL20 and gK
highlighting (Jambunathan et al., 2014). Also, the cytoplasmic portion of gD has been shown to
bind directly to the capsid (Chi et al., 2005).
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Figure 2.14: Schematic illustration of viral protein interactions during secondary envelopment.
Yellow rectangles denote tegument proteins. Adapted with permission from PhD dissertation
titled “The Role of Viral Glycoproteins and Tegument Proteins in Herpes Simplex Virus Type 1
Cytoplasmic Virion Envelopment” by Dmitry V. Chouljenko, Louisiana State University, School of
Veterinary Medicine, Department of Pathobiological Sciences, August 2014.
gK and the non-glycosylated membrane protein UL20 play important roles in
cytoplasmic envelopment and egress(Foster and Kousoulas, 1999; Jambunathan et al., 2014).
And as discussed above, the gD (carboxyl terminus), gE, gM, and the membrane-associated
protein UL11 play important roles in cytoplasmic virion envelopment and egress from infected
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cells. The relative importance of gD, gE, gM, gK, pUL20 and pUL11 in virion secondary
envelopment and egress have been studied. Lack of gK and UL20 causes the most severe
perturbances in virion envelopment and egress (Chouljenko et al., 2012; Foster and Kousoulas,
1999; Jambunathan et al., 2014).
Nucleocapsids obtain envelops as they bud into vesicles derived from TGN. These
vesicles are enriched with viral envelope glycoproteins. This budding process is topologically
similar to the formation of intraluminal vesicles in multivesicular bodies in cells. Formation of
intraluminal vesicles in multivesicular bodies is mediated by the endosomal sorting complexes
required for transport (ESCRTs) and the ATPase VPS4 complexes. Experiments using
ESCRTdominant-negative cells, as well as RNA interference experiments revealed that ESCRT
proteins are likely involved in virion envelopment in both HSV-1 and HCMV. It has been shown
that gK possesses a putative ESCRT-binding motif which possibly participates in the recruitment
of ESCRT protein to facilitate membrane curvature during the budding process. Interestingly,
ESCRT-III proteins and VPS4A/B have been shown to be incorporated into mature HSV-1 virions
(Pawliczek and Crump, 2009).
Egress of enveloped virions
After secondary envelopment, enveloped virions enclosed within TGN derived vesicles
are transported to the plasma membrane and released to the extracellular space via exocytic
pathways(Johnson and Baines, 2011; Mettenleiter, 2002; Mettenleiter et al., 2009). The
transport process is assisted by myosin Va and the cellular serine-threonine protein kinase D.
Myosin Va translocate enveloped virion laden cellular vesicles along cortical actin filaments
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(Roberts and Baines, 2010). The cellular serine-threonine protein kinase D is involved in scission
of TGN vesicles. It also regulates their transport to the basolateral cell membrane (RemillardLabrosse et al., 2009). In polarized epithelial cells, TGN-derived vesicles containing enveloped
virions are sorted to cell-cell junctions where they fuse with the plasma membrane and release
virions (Mettenleiter, 2002). Sorting of virus containing TGN vesicles to cell junctions is
presumably mediated by gE/gI membrane protein complex and the inner tegument protein
pUL37 (Johnson et al., 2001; Pitts et al., 2014). Placing virions at the cell to cell junction
facilitates cell to cell spread and protects the virus from exposure to host immune response
elements such as antibodies and complement (Johnson and Baines, 2011). Syncytial cells are
large multinucleated cells formed by the fusion of cell membranes of multiple cells after
infection in vivo. Plasma membranes of infected cells are enriched with viral glycoproteins.
Viral entry fusion machinery expressed on infected cell membranes mediate the fusion of
adjacent cells creating syncytia. Syncytia formation is particularly beneficial to the virus as it
helps the virus hide from immune surveillance (Roizman et al., 2007). The fusion of TGNderived vesicles containing enveloped virions is unlikely mediated by viral glycoprotein
embedded in the vesicles membranes. Viral glycoproteins embedded in TGN-derived vesicles
are oriented so that the carboxyl termini are to the cytoplasm. The amino termini of these
glycoproteins are located within the vesicles and do not come in contact with the cell plasma
membrane to mediate fusion (Johnson and Baines, 2011).

57

Retrograde and Anterograde Transport of Alphaherpesviruses in Neurons
Neuronal structure and axoplasmic transport
Neurons are highly polarized cells with unique structure; they are composed of cell
bodies which contain the nucleus, and highly active RNA transcription machinery known as Nissl
substance. Neurons have dendritic extensions and an axon that specializes in initiation;
propagation and transmission of electrical impulses. The axon has an efficient transport system
for long distance cargo transport to move molecules and organelles between the body of the
body of the neuron and axonal termini. Microtubules are key structural elements in the axon.
Microtubules are composed of heterodimeric subunits of alpha and beta tubulins that assemble
in a linear head to tail configuration to form protofilaments. Then, 13 protofilaments form a
hollow conduit, approximately 24 nm in diameter. Microtubules assemble from Microtubule
Organizing Center (MTOC) with distinct polarity; in the axon they are oriented so that an active
+ end is towards the axonal termini, whereas, a stable – end is oriented towards the MTOC. In
dendrites, microtubules have mixed polarity. The end microtubule at the proximal axon
contains filamentous actin, microtubule end binding (EB) proteins EB1 and EB3. Ankyrin G acts
as a scaffold to anchor these structural components together. The proximal axon and its
complex elements regulate the transport of cellular components to the axonal compartment
(Kramer and Enquist, 2013), (Hedstrom et al., 2008; Leterrier et al., 2011; Song et al., 2009).
Transport within axons is mediated by two classes of motor molecules kinesin and
dynein. Both use ATP hydrolysis to drive the transport. Dynein is a 1.2 megadalton that contains
heavy chains, intermediate chains, light intermediate chains and light chains. Dynein forms a
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dynactin complex with multiple subunits to bind various molecules. Dynein motor molecule
mediates microtubule-dependent retrograde transport (towards the – end). Kinesin superfamily
(KIF) is markedly more diverse. KIFs are classified into 3 broad categories; N-kinesins Mkinesins, C-kinesins depending on the position of the motor domain; near the amino terminus,
near the middle, or near the carboxyl terminus, respectively. KIFs mediate microtubule
dependent transport towards the + end (anterograde transport) (Diefenbach et al., 2008;
Goldstein and Yang, 2000; Hirokawa et al., 2009; King, 2000; Schroer, 2004).
Virus binding, attachment and entry
Mature infectious virion particles initiate the infection of neurons virion attachment to
the cellular receptors. The envelope glycoprotein gC and gB attach to glycosaminoglycane
chains of heparan sulfate proteoglycanes, this initial attachment does not require energy
(Kramer and Enquist, 2013; Laquerre et al., 1998; WuDunn and Spear, 1989). After that, gD
binds to a wide variety of receptors on cell membrane. Cellular receptors for gD include
members of tumor necrosis factor receptor family (TNF) such as herpes virus entry mediator A
(HVEM or HveA). Members of immunoglobulin superfamily also serve as receptors for gD;
examples include nectin-1, nectin-2, paired immunoglobulin-like type 2 receptor alpha (PILR-2
alpha) and 3-O sulfated heparan sulfates. Nectin-1 is present on the sensory neuronal endings.
VZV encodes gE that may have gD like functions during binding, a proposed receptor for VZV gE
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is the insulin degrading enzyme. Binding of gD to its cognate receptor triggers conformational
changes in gB, gH, and gL which leads to the fusion of viral envelope with cell membrane.
(Heldwein and Krummenacher, 2008; Kramer and Enquist, 2013; Li et al., 2007; Roizman et al.,
2007).
During binding and fusion, viral tegument proteins are reorganized to become
asymmetrically distributed so that the dense aggregation faces away from the cell (Meckes and
Wills, 2008; Smith, 2012). HSV-1 enters neuronal cells via a pH-independent fusion of the viral
envelope with neuronal plasma membranes (Nicola et al., 2005; Qie et al., 1999), while it can
enter a wide range of non-neuronal cells via either pH independent or pH-dependent
endocytosis (Milne et al., 2005).
Viral tegument proteins are classified into inner and outer tegument proteins. Inner
tegument proteins are: pUL14, pUL16, pUL21, pUL36, pUL37, pUS3, and ICP0 (Kramer and
Enquist, 2013; Radtke et al., 2010). Outer tegument proteins are; pUL46, pUL47, VP16, and
VP22 (Luxton et al., 2005; Smith, 2012). Tegument proteins dissociate from the capsid upon
entry into the cytosol. However, a subset of inner tegument proteins (UL36, UL37 and US3)
remain attached to the capsid. These three inner tegument proteins participate in the
retrograde axonal transport of capsid to the nucleus (Copeland et al., 2009; Kramer and
Enquist, 2013; Luxton et al., 2005; Smith, 2012).
Retrograde transport
After virus-cell membrane fusion and deposition of capsid and the attached inner
tegument proteins in the cytosol, the capsid is transported in retrograde manner to the
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nucleus. It has been shown recently that alphaherpesviruses induce local protein synthesis in
axons for efficient retrograde transport. Proteins involved in cytoskeletal reorganization, cell
singling and metabolism are among the infection induced proteins (Koyuncu et al., 2013).
Retrograde transport depends on intact microtubules and the motor complex; Dynein
and the dynein co-factor dynactin. Alphaherpesvirus capsids transport to the nucleus at a rate
of 1 µm/s which is consistent with the fast retrograde axonal transport. As expected capsid
transport was abolished when cells were pretreated with microtubule depolymerizing agent
such as Nocodazol and colchisin. This indicates that the virus exploits and piggy back on
preexisting axonal transport mechanisms. Multiple capsid and tegument proteins have been
proposed to be involved in the recruitment of dynein motor molecule for retrograde transport.
pUL34 and pUL9 have been shown to bind to dynein 1 intermediate chain (DYNC11)1a, and LC8
respectively, in vitro (Diefenbach et al., 2008; Kramer and Enquist, 2013; Ye et al., 2000).
However, neither is incorporated in mature virion particles. Moreover, deletion of pUL34 did
not prevent infection with HSV-1 (Reynolds et al., 2002; Roller et al., 2000). UL35 encodes VP26;
a structural capsid protein. Studies have demonstrated that VP26 interacts with the dynein light
chain (Tctex-1), both in yeast two-hybrid system and in vitro (Diefenbach et al., 2008; Douglas
et al., 2004). Inner tegument proteins UL36, UL37 and US3 have emerged as candidates for
virus-motor molecule interaction. Deletion of UL37 and US3 did not cause dramatic disruption
in viral retrograde transport. However, UL36 null mutants were largely unable to reach the
nucleus (Kramer and Enquist, 2013; Luxton et al., 2006). US9 null viruses do not exhibit defects
in the retrograde transport (Brideau et al., 2000a).
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Deposition of Viral DNA into the nucleus
After capsids reach the minus end at the MTOC, they translocate to the nuclear pore
complex where viral DNA is released into the nuclear pore. Proteolytic cleavage of UL36 after
docking to the NPC induces conformational changes that lead to the release of viral DNA into
the nucleus (Jovasevic et al., 2008). pUL25 capsid protein have been shown to interact with
nuclear pore complex components (Nup 214 and hCG1). It is possible that this pUL25 plays a
role in DNA release into the nucleus (Smith, 2012). Once inside the nucleus the linear viral DNA
circularizes and serves as a template for replication (Roizman et al., 2007).
Nuclear egress
A heterodimeric complex composed of pUL34 and pUL 31 (NEC) mediates the primary
envelope-mediated nuclear egress of the nucleocapsid into the perinuclear space. This complex
recruits viral kinases (US3 and pUL13) and cellular protein kinase C to locally phosphorylate and
soften the nuclear lamina. (Leach and Roller, 2010; Mettenleiter et al., 2013). The initial
budding through the inner nuclear membrane is followed by fusion and de-envelopment event
at the outer nuclear membrane. pUS3 is involved in the de-envelopment and translocation of
nucleocapsid from the periuclear through the outer nuclear membrane (Mettenleiter et al.,
2013; Mou et al., 2009).
Married model vs separate model in anterograde transport
The mechanism of anterograde transport of alpha herpesvirus in neuronal cells is highly
controversial, to a large extent because of disparate results obtained with pseudorabies virus
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(PRV) and HSV-1. Two principal mechanisms of axonal transport have been proposed: (i)
independent axonal transport of viral glycoproteins and capsids and assembly of the enveloped
virions in the plasma membrane (separate model) and (ii) transport of fully enveloped virions
that have formed via budding of capsids into TGN-derived membranes (married model)
reviewed in (Diefenbach et al., 2008; Kratchmarov et al., 2012).
Evidence for the married model. Live cell imaging of double labeled viruses in proximal
and distal regions of axons after infection of primary neuronal cultures of dorsal root ganglia
(DRG) of embryonic rats revealed that there is a co-localization of capsid and membrane
protein signals during anterograde experiments. Antinone et al 2006 have constructed
recombinant PRV viruses with GFP labeled gD and mRFP labeled Vp26 (Antinone and Smith,
2006). The two fluorescent signals co-localized in 86% of particles traveling in anterograde
direction. However, 14 % of mRFP signal had no GFP signal associated with it. This lack of colocalization can be attributed to limitations in detectability. Taylor et al 2012 had similar dual
signal using GFP-US9 labeled PRV virus (Antinone and Smith, 2006; Taylor et al., 2012). Imaging
of dual-fluorescent HSV-1 recombinant viruses were shown to support the married model. HSV
virus expressing mRFP-VP26 and GFP-gB was reported to have 70% co-localization of both
signals in chicken and rat DRG(Antinone et al., 2010). Recent high resolution electron
microscopic imaging of neurons infected with PRV or HSV-1 showed that the majority
(approximately 70%) of virions travel in anterograde manner are enveloped (Negatsch et al.,
2010).
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Evidence for the separate model. Immunofluorescent antibody (IFA) technique was
used to determine the assembly state of virion particles in anterograde set up experiments.
Fluorescent antibodies against capsid proteins and envelope proteins have shown minimal colocalization supporting the separate model (Snyder et al., 2006). Cell imaging using cryoelectron tomography on hippocampal axons revealed that axons predominantly contained
naked capsids (Ibiricu et al., 2011).
It is clear that the support for the separate model tends to depend on negative
evidence. Limitations of detection in IFA techniques would significantly confound the final
interpretation. Also, hippocampal neurons tend to develop long and arborized dendrites, and
the cryo-electron microscopy pictures were obtained without identification of the exact
sections of axons. Transport in dendrites has not been characterized before. Therefore, the
assembly status of the virion traveling in dendrites in anterograde manner may not be the same
as in axons (Kratchmarov et al., 2012).
Anterograde transport
Once in the cytosol, nucleocapsids obtain inner tegument proteins including UL36, UL37
and US3. UL 36 is essential for secondary envelopment and egress events. UL36 also interacts
with motor proteins to transport the capsid to the site of secondary envelopment. The
nucleocapsids and associated tegument composition of incoming virions is similar to the newly
formed. Which pauses the question; how are capsids differentially directed to the nucleus upon
entry or to the site of secondary envelopment during egress?. Post translational modifications
or other subtle but important differences in tegument component may govern the differential
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targeting of capsids to the nucleus during entry, and newly formed capsids to the site of
secondary envelopment (Kramer and Enquist, 2013; Smith, 2012).
UL36 and US11 are viral protein candidates for recruitment of kinesin motor molecules
during anterograde transport. Both proteins have been shown to interact with kinesin in
biochemical assays. However, UL36 and US11 are components of virion tegument and they are
unlikely to participate in the anterograde transport of enveloped virions. (Kramer and Enquist,
2013).
US9, gE and gI play important roles in sorting enveloped virions into the axonal
compartment. HSV-1 gE is a type 1 membrane glycoprotein of 552 amino acids. gE is expressed
as a heterodimer with gI; the complex facilitates cell to cell spread by sorting newly formed
virion particles to cell junctions and lateral cell surfaces (Collins and Johnson, 2003).
The cytoplasmic tail of PRV gE (last 123 amino acids) contains tyrosine based
internalization motif (specifically amino acids 478-481). This motif is important in gE/gI
constitutive endocytosis from the plasma membrane. gE-null or gE cytoplasmic tail deleted
viruses have a small plaque phenotype in non-neuronal- cell type, and defective for
anterograde spread in neurons in vivo (Brideau et al., 2000b; McGraw et al., 2009). gE/gI
complex also stabilizes the interaction of US9 with KIF1A (kinesin motor protein important in
anterograde transport) (Kratchmarov et al., 2013a).
US9 is a type II membrane anchored protein. US9-null viruses produce similar plaquesize as wild type in epithelial cell tissue culture. However, mutants lacking US9 are defective in
anterograde transmission (Chowdhury et al., 2011; Lyman et al., 2007; Taylor et al., 2012). US9
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was also found to interact with KIF1A(Kramer et al., 2012). US9 has an acidic cluster of 10
amino acids, within the cluster Y49 and Y50 are known to be required for US9-KIF1A interaction
and to be important for productive anterograde spread in vivo (Brideau et al., 2000b; Kramer et
al., 2012; Kratchmarov et al., 2013b). Moreover, phosphorylation of two serine residues S51&
S53 in the acidic cluster of US9 was shown to be essential for anterograde spread in vivo
(Brideau et al., 2000b; Kratchmarov et al., 2013b). Although not essential, phosphorylation of
the two serine residues S51 & S53 enhances the US9-KIF1A based transport (Kratchmarov et al.,
2013b). The S51 & S53 serine residues in US9 are conserved in BHV-1, HSV-1, HSV-2, VZV, EHV1, BHV-1, BHV-5 (Chowdhury et al., 2011) and PRV.
Herpes Simplex Virus Diseases
Herpes simplex virus infection causes a wide range of clinical manifestations ranging
from vesicles on the mucocutaneous membranes to fatal encephalitis (Roizman et al., 2007).
Being an enveloped virus, HSV-1 is susceptible to desiccation, UV radiation, and lipid solvents.
Therefore, transmission of the virus is by the direct and intimate contact with individuals
shedding the virus. After infection the virus is shed from the site of infection for 7-10 days (Amir
et al., 1997). Serum neutralizing antibodies can be detected as early as 4-7 days post infection
and peak at 3 weeks post infection (Buddingh et al., 1953). The seroprevalence for Herpes
simplex virus in USA and Europe is estimated to be 70-85% (Fatahzadeh and Schwartz, 2007;
Looker and Garnett, 2005; Nahmias et al., 1990). Seroprevalence to HSV-1 is more common
than to HSV-2(Nahmias et al., 1990). HSV-1 usually is an oral infection whereas HSV-2 infects
genitalia. Increasing reports have showed that both viruses have been detected at alternate
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sites; however, HSV-1 infections of the genitalia tend to be less severe with lower frequency of
recurrence (Corey et al., 1983; Kalinyak et al., 1977). Approximately 30% of genital herpes
infections in the U.S. are caused by HSV-1. However, in specific populations such as college
students in the US, HSV-1 accounts for up to 78% of genital isolates (Kimberlin, 2014; Roberts et
al., 2003). A global prevalence study showed that the total number of people aged 15-49 years
who are infected with HSV-2 in 2003 is 536 million (Looker et al., 2008).
Herpes labialis
Herpes labialis or cold sore is infection of the mucocutaneous areas of the lips and
mouth. It is the most common manifestation of herpes simplex infection (Roizman et al., 2007;
Whitley and Miller, 2001). The virus infects and replicates in epithelial cells of the oropharynx.
This primary infection may result in vesicular lesions or bullae at the site of inoculation, but the
primary infection can also be asymptomatic. Histologically; the bulla will appear as an
intraepidermal vesicle containing serofibrinous fluid and swollen, acantholytic keratinocytes,
some of which has eosinophilic intranuclear inclusion bodies (Figure 2.15).
Vesicles may rupture leading to erosion and ulceration, and occasionally the herpes
infection is complicated by secondary bacterial infection. The virus eventually infects sensory
nerve endings and transports to the body of the neuron in the trigeminal ganglia where it
establishes persistent (latent) infection for the life of the host. Triggered by a number of stimuli
such as stress and UV light, latent virus may reactivate resulting in the transport of the virus to
the initial site of infection where it replicates and causes outbreaks of recurrent vesicular
lesions (Baron et al., 1996; Roizman et al., 2007).
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Figure 2.15: Hematoxylin and eosin stained histological section of herpes labialis showing an
intraepidermal vesicle containing serofibrinous fluid and swollen, acantholytic keratinocytes,
some of which has eosinophilic intranuclear inclusion bodies. The dermis is infiltrated with
inflammatory cells. Adapted from Weedon: Skin Pathology 3rd edition (2010).

The frequency and the severity of the recurrent infection varies between individuals,
approximately 30% of seropositive individuals experience recurrences with 40% of them have a
recurrence once a year (Wald and Corey, 2007). Recurrent disease is often presented with
tingling or itching, and pain for nearly 6 hours. These symptoms are then followed by the typical
cold sore vesicle formation within 24-48 hours (Spruance, 1984; Spruance et al., 1977)
(Spruance and Crumpacker, 1982). The vesicular lesion usually resolves on average after seven
days (Segal et al., 1974; Ship et al., 1977). Recurrent infection and viral shedding can also be
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asymptomatic (Fatahzadeh and Schwartz, 2007; Koelle and Wald, 2000). Intraoral and
pharyngeal lesions accompanied by fever are known as Gingivostomatitis are more common in
children younger than five years old (Roizman et al., 2007).
Herpes simplex ocular disease
Herpes simplex ocular disease is one of the serious consequences of HSV infection.
Ocular herpes virus infection is the leading cause of infectious blindness in the developed
world. Approximately 400,000 people in the United States have suffered herpes simplex ocular
disease with 58,000 total episodes per year. A recent study has estimated the average annual
incidence of new cases to be 11.8 per 100,000 population. The prevalence is approximately 149
cases per 100,000 population (Liesegang, 2001; Liesegang et al., 1989; Young et al., 2010).
Primary ocular infection can cause ocular disease, but frequent episodes of reactivation
lead to more devastating consequences. Herpes simplex virus infected eyes manifest as
conjunctivitis, blepharitis, ocular discharge and keratitis (Darougar et al., 1985; Rowe et al.,
2013; Zhu and Zhu, 2014). The majority of herpes ocular infections are caused by HSV-1 rather
than HSV-2 (Roizman et al., 2007). Herpes virus infection of the cornea can be divided into;
epithelial keratitis which accounts for 50%-80% of all ocular herpes infection, and stromal
keratitis (Labetoulle et al., 2005; Wilhelmus et al., 1981).
In epithelial keratitis, the virus replicates in corneal epithelial cells and causes epithelial
cell destruction. It manifests initially as small vesicles that coalesce and ultimately rupture
leading to what is known as dendritic ulcers. Dendritic ulcers in the cornea appear as central
ulcerations with raised borders, and terminal end bulb (Figure 2.16). Inflammatory cell
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infiltrates include polymorphonuclear cells, lymphocytes and plasma cell, occasional syncytial
cell formation and eosinophilic intranuclear inclusions (Maudgal and Missotten, 1978; Metcalf
and Reichert, 1979).

Figure 2.16: Epithelial keratitis caused by HSV-1; Dendritic ulcer in the corneal epithelium
shown here with fluorescein staining. The image was taken from
http://medilinks.blogspot.com/2012/01/photos-for-herpes-simplex-keratitis-hsk.html

Stromal keratitis is characterized by stromal edema, neovascularization, necrosis and
inflammatory infiltrates. Repeated bouts of reactivation lead to corneal stromal scaring. Even
after clearance of inflammatory cells, new blood vessel growth in the cornea and the
destruction of the structural integrity of the stroma cause marked opacity and vision
impairment (Figure 2.17) (Zhu and Zhu, 2014) (Rowe et al., 2013) (Gimenez et al., 2013).
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Figure 2.17: Slit lamp photograph of Herpes simplex stromal keratitis. Note stromal opacity and
neovascularization of the cornea (Rowe et al., 2013).

The infection can spread to deeper eye structures and cause infection and inflammation
of the anterior chamber, iris and retina (David et al., 2008; Holland et al., 1987; Liesegang,
2001).

However, the acute retinal necrosis, iridocyclitis and panuveitis are rare in

immunocompetent individuals (Zhu and Zhu, 2014). Severe stromal destruction and corneal
opacity may be treated with corneal transplants, however, reactivation of latent virus from the
trigeminal ganglia can cause graft failure(Cockerham, 2001; Cockerham et al., 1997; De Kesel et
al., 2001; Tullo, 2003).
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One of the possible consequences of herpes ocular infection is neurotrophic
keratopathy; a loss of sensation in the cornea due to degeneration of sensory nerves (Hamrah
et al., 2012; Liesegang, 1999). Loss of sensation in the cornea may also lead to reduction in tear
film production (dry eye), which increases the chances for corneal abrasions and ulcerations,
inflammation, secondary bacterial infection and increased frequency of herpetic ocular
recurrences (Tullo, 2003) (Keijser et al., 2002).
Role of corneal epithelial cells in the pathogenesis of primary herpes keratitis. The
annual incidence of new cases of herpes keratitis is 11.8 per 100,000 population (Liesegang et
al., 1989; Young et al., 2010). Infection starts by the entry and replication of the virus in
epithelial cells at site of exposure, followed by entry into sensory neurons via their axonal
termini. The virus recruits cellular transport machinery to translocate in retrograde manner to
the body of the neuron. In the neuronal cell body, the virus remains latent for the life of the
host. Exposure to UV light or immunosuppression leads to bouts of reactivation whereby the
virus transports in anterograde manner to the primary site (Roizman et al., 2007).
The innate immune system is the first line of defense against pathogens. Cells of the
innate immune system are equipped with Pattern Recognition Receptors (PRRs) which serve as
sensors for conserved pathogen associated molecular patterns (PAMPs) displayed on the
invading pathogens(Boehme and Compton, 2004). Toll like Receptors (TLRs) are a class of PRRs
that are expressed predominantly on cells that are likely to first encounter the pathogen.
Professional antigen presenting cells and phagocytic cells express the highest levels of TLRs
(Akira et al., 2006; Medzhitov, 2007). In general, binding of PAMPs to TLRs leads to the
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production of pro-inflammatory cytokines, and interferons, and up regulation of co-stimulatory
molecules(Yamamoto and Takeda, 2010).
Corneal epithelial cells are one of the most important active participants in herpes
Simplex keratitis. They are the first cell type to encounter the virus upon primary ocular
infection with HSV. Corneal epithelial cells not only take part in pathogen recognition via the
expression of a wide range of PRR including TLR-2, TLR-7 and TLR-9 (Johnson et al., 2005;
Kumar et al., 2006; Li et al., 2006) but also secrete β-defensins, cytokines and chemotactic
factors upon microbial invasion(Akpek and Gottsch, 2003).
TLR2 plays a key role in the recognition of a wide range of in microbial antigens from
bacteria, fungi, parasites and viruses reviewed in (Kawai and Akira, 2010). TLR2 generally forms
heterodimers with TLR1 or TLR6. Moreover, TLR2 has the ability to act together with other cell
surface receptors to assist PAMP recognition. These include CD36 and CD14 (Hoebe et al., 2005;
Jiang et al., 2005). Generally, binding of PAMPs to TLR-2 leads to the downstream signaling
through MyD88 dependent pathway which activates NF-kB and promotes the production of
pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and IL-12 (Kawai and Akira, 2010). It has
been demonstrated that TLR-2 recognizes structural components of viruses (Bieback et al.,
2002; Cooper et al., 2005). Members of herpes virus family bind to and activate TLR-2 MyD88
dependent pathways (Ariza et al., 2009; Boehme et al., 2006; Wang et al., 2005). HSV-1 gB has
been shown to interact with TLR-2 which leads to pro-inflammatory cytokine production via
MyD88 dependent signaling. This binding and downstream cascade activation did not require
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CD14 (Cai et al., 2013; Leoni et al., 2012; Sato et al., 2006). HSV-1 gB recognition occurs
predominantly by TLR-2/TLR6 heterodimer and to a lesser extent by TLR-2/TLR heterodimer
(Cai et al., 2013).
Following a primary infection with HSV-1, the cornea is infiltrated with a diverse set of
inflammatory cells composed of; neutrophils (the predominant cell type), macrophages, natural
killer cells (NK), T cells, and corneal dendritic cells (Miller et al., 1996; Stuart and Keadle, 2012).
The development of primary herpes keratitis is believed to be a result of interaction of virus
with the innate immune system rather than a direct viral cytopathic effect on corneal
cells(Stuart and Keadle, 2012).
During primary keratitis, the infection induces the production of IL-6, which stimulates
the production of neutrophils chemotactic factors (CCL3 and CXCL2). CCL3 and CXCL2 along
with CCL1, CCL4, CCL5 CXCL10 attract monocytes, NK cells and DCs(Stuart and Keadle, 2012).
Also, the levels of pro-inflammatory cytokines IL-1 alpha and IL-6 were increased upon primary
herpes corneal infection. This increase was followed by an overlapping set of cytokine
production (IFN-gamma, IL-12, IL-17, IL-4 and IL-10). This cytokine profile is indicative of the
involvement of CD4+ T cells; Th1 and Th17 in the immune response (Biswas et al., 2004;
Niemialtowski and Rouse, 1992; Stuart and Keadle, 2012). CD8+ cells play a minor role in the
disease(Stuart and Keadle, 2012).
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TLR-2 pathway activation is responsible for the detrimental inflammatory cytokine
production that culminates in immunopathology (Sarangi et al., 2007; Wang et al., 2012). On
the other hand, resistance to acute HSV-1 infection is mediated by p204 / IFN-inducible protein
16 (IFI-16). CD Conrady et al suggested that recognition of HSV-1 by the innate cytoplasmic
sensor (IFI-16) is the principal initiator of IFN production in the cornea. IFI-16 initiates IFN
production through stimulator of interferon genes (STING) dependent manner (Conrady et al.,
2012).
Recently, the interaction between DC and NK in the development of HSK has been under
increased scrutiny. Frank et al have studied the role of dendritic cells as well as the interaction
between DC and NK in the cornea during primary HSV-1 keratitis(Frank et al., 2012). He showed
that DCs are necessary for optimal clearance of HSV-1 from the cornea. However, they assume
this function by directing local NK cells which in turn, serve as the proximal mediator of viral
clearance from the cornea(Frank et al., 2012).
Herpes simplex encephalitis
Herpes simplex virus is the most common cause of viral encephalitis worldwide (Aryee
and Thwaites, 2015). Herpetic encephalitis is rare in immunocompetent individuals. In
immunocompromised adult patients; primary or recurrent infection can result in encephalitis
(Fatahzadeh and Schwartz, 2007). Of the 7.3 million hospitalizations for encephalitis in the US
between 1979-1988, Herpes simplex virus accounts for 10% of the cases (Stahl et al., 2011a;
Stahl et al., 2011b). Herpes simplex encephalitis has an incidence of 1 in 250,000–500,000
individuals (Baringer, 2008; Whitley, 2006). If left untreated, herpes simplex encephalitis has a
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70% fatality rate (Wald and Corey, 2007). Only 2.5 % of survivors returned to normal function,
the remaining patients may sustain some degree of dysfunction (Whitley, 2006).

Ninety

percent of herpetic encephalitis cases in adults are caused by HSV-1, whereas, HSV-2 is a more
common cause of encephalitis in neonates (Ito et al., 2000). The virus gains access to the
central nervous system (CNS) in primary infection through the olfactory and trigeminal nerves.
Reactivation of a latent virus can lead to transport of virions to the CNS causing encephalitis
(Whitley, 2006). The classical clinical presentation of herpetic encephalitis is headache, fever,
neurologic deficits and altered mental state. However, these clinical signs are not
pathognomonic (Whitley, 2006).
At early stages of herpetic encephalitis, the brains of affected adults show bilateral,
asymmetrical acute inflammation, congestion, and/or hemorrhage, most prominently in the
temporal lobes. The meninges overlaying the affected areas appear congested or cloudy. After
two weeks, the changes progress to liquefactive necrosis (Figure 2.18). Histologically, there is
congestion of meninges and the cortex and subcortical white matter at early stages; however,
at late stages (after two weeks), hemorrhagic necrosis, perivascular cuffing and glial nodules
become evident. Inflammation consists of mononuclear infiltrates, gliosis and satellitosis and
neuronophagia. Found in only 50% of patients, intranuclear inclusion bodies are most often
visible in the first week of infection. The intranuclear inclusion bodies (Cowdry type A
inclusions) are characterized by an eosinophilic homogeneous appearance surrounded by a
clear zone with marginated chromatin (Figure 2.19) (Booss and Kim, 1984; Kapur et al., 1994;
Stahl et al., 2011a; Whitley, 2006). Cases of aseptic meninges are rare and the changes seen are
mononuclear inflammatory cell infiltrates in the meninges and a slight increase in mononuclear
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cell counts in the cerebrospinal fluid (CSF) (Dudgeon, 1969; Koskiniemi et al., 1980; Skoldenberg
et al., 1984). Diagnosis of herpetic encephalitis relies on the presence of clinical signs, MRI
imaging, PCR on brain biopsies and CSF, histopathological findings, serological tests (CSF) and
viral isolation (Cinque et al., 1996; Whitley et al., 1989).

Figure 2.18: Herpetic encephalitis. Bilateral asymmetrical necrohemorrhagic encephalitis,
temporal and frontal lobes. Adapted from laboratory medicine, Yale school of medicine
website; http://labmed.yale.edu/education/cme/casestudies/7/10.aspx. The website credits
University of Iowa College of Medicine Virtual Hospital, Dr. Gary Baumbach, M.D., Department
of Pathology, for the picture.
Neonatal infections
Infection of neonates with HSV can occur in utero (intrauterine), intrapartum and
postpartum. Intrapartum infection constitute the most common mode of infection (75-80% of
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the cases), whereas, postpartum infection accounts for approximately 10% of the cases (Brown
et al., 2003). The majority of intrapartum neonatal infections are caused by HSV-2, however,
HSV-1 infection may also occur (Roizman et al., 2007). Intrauterine infections are very rare, but
they often have detrimental consequences such as disseminated cutaneous lesions and
multiple developmental abnormalities including:

lissencephaly, microphthalmia and

microcephaly to mention a few (Hutto et al., 1987; Roizman et al., 2007).

Figure 2.19: Hematoxylin and eosin stained histological section of the brain. Intranuclear
inclusion bodies (Cowdry type A inclusions) are characterized by an eosinophilic homogeneous
appearance surrounded by a clear zone with marginated chromatin. Adapted from laboratory
medicine, Yale school of medicine website;
http://labmed.yale.edu/education/cme/casestudies/7/11.aspx. The website credits Dr. Peter
Anderson, University of Alabama at Birmingham, Department of Pathology, for the image.

There are estimated 1500 cases of neonatal infections with HSV per year in the US
whereby the infection rate is 1 in 3000 births. Risk of transmission dramatically decreases with
caesarean section delivery, or if the mother seroconverts before delivery (Brown et al., 2003;
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Johnston et al., 2008). Neonatal infection with HSV can result in a wide range of clinical
presentations including disseminated disease, central nervous system disease, or cutaneous
disease. Forty five percent of neonatal infections involve the mouth, eye and skin. Thirty
percent of the cases are central nervous system disease, and the disseminated disease accounts
for the remaining 25% of the cases (Kimberlin, 2001; Kimberlin et al., 2001; Pinninti and
Kimberlin, 2013a, b; Whitley, 1988). Although disseminated HSV disease has a higher mortality
rate (29%) than CNS disease (4%), the frequency of disabilities is much lower. 69% of neonatal
CNS disease cases suffer from disability and retarded brain development 1 year after the
disease compared to 17% of disseminated disease cases (Pinninti and Kimberlin, 2013b).
Symptoms of disseminated disease and CNS infection in neonates are not specific. The
sings include; fever, anorexia, respiratory distress and lethargy. Disseminated disease in
neonates involves the spread of the virus to multiple visceral organ systems (lungs, liver, eyes,
skin, and brain) causing severe complications such as pneumonia, hepatitis, encephalitis and
coagulopathy. Central nervous system infection in neonates is similar to herpetic encephalitis
in adults (Thompson and Whitley, 2011).
Herpes simplex virus infection in immunocompromised patients
Immunocompromised individuals are at a greater risk of severe, more common, and
greater spread of primary or recurrent HSV infections. Impaired immune system function may
occur due to metabolic disturbances and malnutrition, immunosuppressive therapy for cancer
treatment or organ transplant, or acquired immunodeficiency syndrome (AIDS). The clinical
manifestations of HSV infection in such patients ranges from vesicular dermatitis to esophagitis,
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pneumonitis, colitis, and devastating systemic infections (Fatahzadeh and Schwartz, 2007;
Roizman et al., 2007). More incidents of reactivation (60-95%) have been observed in
immunosuppressed individuals (Arduino and Porter, 2008). It is noteworthy to mention that
HSV-2 infection increases the risk of acquiring HIV by 2-4 folds. Also HSV-2-seropositive
individuals have a 5-fold greater risk of acquiring HIV compared with HSV-2-negative individuals
(Corey et al., 2004; Wald and Link, 2002).
Prevention and Treatment of Herpes Simplex Infection
Elimination of contact with seropositive individuals, the use of therapeutics and vaccines
represent the main strategies to prevent and treat herpes virus infection. Preventative
measures such as maintaining good hygiene, avoiding contact with infected individuals and
using barrier methods during sexual activity such condoms would be ideal to eliminate contact
with seropositive individuals. Unfortunately, this preventive measure is difficult to implement
due to asymptomatic shedding. Seventy percent of HSV-1 infected persons shed the virus from
the oral cavity at least once a month with many of the shedding incidents are without
symptoms (Miller and Danaher, 2008).
Anti-herpes virus therapeutic agents have been effective in reducing the duration of
primary and recurrent infection as well as the symptoms. Acyclovir is effective against HSV-1,
HSV-2, VZV and EBV (Kaye, 2009). It inhibits viral DNA polymerase activity and viral DNA
synthesis. Acyclovir is a nucleoside analogue that mimics deoxyguanosine but lacks the 3’
hydroxyl moiety. In infected cells, viral thymidine kinase monophosphorylates acyclovir.
Subsequently, cellular kinases convert acyclovir monophosphate to acyclovir triphosphate by
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adding 2 additional phosphates. Acyclovir is incorporated in the growing DNA strand instead of
deoxyguanosine triphosphate (dGTP). As a result, DNA polymerase is inhibited and DNA strand
elongation is terminated (Coen, 2007; Wilson et al., 2009). Viral specificity of acyclovir is
reflected in the fact that; 1) acyclovir is selectively phosphorylated by viral TK kinase at a higher
efficiency than mammalian thymidine kinase, 2) acyclovir inhibits cellular DNA polymerase
weakly compared to viral DNA polymerase (Kleymann et al., 2002) (Crumpacker and Schaffer,
2002; Wilson et al., 2009). The emergence of acyclovir resistant HSV stains (approximately 6%
of HSV isolates from HIV infected patients are acyclovir resistant), and the limited oral
bioavailability of acyclovir pose significant problems. Therefore, alternatives to acyclovir have
been researched in recent years. Foscarnet is a pyrophosphate analog that has been used as an
alternative to acyclovir. Foscarnet inhibits viral DNA polymerase by preventing the release of
pyrophosphate; a process required for DNA strand elongation. Foscarnet is used as the last
resort because it is nephrotoxic and requires intravenous mode of administration. Valacyclovir,
Famciclovir and Valganciclovir are nucleoside analogues with similar mode of action to
acyclovir, but with improved oral bioavailability (Coen, 2007). New classes of therapeutics such
as aminothiazolylphenyl-containing drugs and thiazole urea derivatives have been
experimentally shown to be promising drug alternatives for the treatment of HSV infections.
These classes of drugs target helicase–primase complex rather than DNA polymerase. The new
drugs increase the affinity of the primase and helicase subunits to DNA strands leading to the
inhibition of viral DNA synthesis (Crumpacker and Schaffer, 2002; Kleymann et al., 2002) (Crute
et al., 2002).
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Many experimental drugs such as glycosylation inhibitors and plant extracts such as Aloe
vera, Swertia chirata and Melissa officinalis, and Toll like Receptor agonists have been
examined for their efficacy and toxicity to be used as anti-herpesvirus therapeutics. Some of
those compounds have shown promising preliminary results.
The goal of development of vaccine therapeutics to HSV is to augment immune
responses against it and to suppress recurrences. HSV vaccine strategies include the
construction of genetically attenuated live virus vaccines, killed or inactivated virus vaccines,
recombinant subunit vaccines, DNA vaccines as well as immunizations with replication
competent and replication incompetent vectors. An example of a recently constructed
genetically modified attenuated live virus vaccine is ACAM529. ACAM529 is an anti-HSV-2
vaccine that has been optimized for commercial manufacturing (Sanofi Pasteur) and is currently
under phase I clinical trials. This vaccine has shown both strong immunogenicity and high
efficacy in vivo (Mundle et al., 2013). Promising results have been observed with HSV-2 liveattenuated ICP0 deletion virus (ICP10DPK) which showed prevention of recurrent disease in
37% and 43.5% of vaccinated individuals in two separate trials (Casanova et al., 2002). Lupidon
H and lupidon G is a whole heat-inactivated virus from HSV-1 and HSV-2, respectively. This
vaccine was shown to reduce incidents of recurrences; however, the results were inconclusive
due to lack of use of proper controls (Weitgasser, 1977). An experimental HSV-2 subunit
vaccine (GEN-003/MM-2) composed of HSV-2 gD2 and a truncated form of ICP4 prepared with
Matrix M-2 (MM-2) adjuvant was able to elicit humoral immune responses, CD4(+) and CD8(+)
T cells resulting in decreased recurrent disease symptoms and reduced the frequency of
recurrent viral shedding in Guiana pigs (Skoberne et al., 2013). Lipopeptide vaccines represent a
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new strategy in vaccine development; the preparations are made for mucosal topical ocular
and intravaginal application. The principle is predicated on the recent findings that HSV
protective epitopes are recognized by T cells from symptomatic individuals versus
asymptomatic (Dasgupta et al., 2009). Recent work in this laboratory has shown that a single
vaccination using a recombinant virus with a mutation in gK and UL20 conferred 100%
protection against lethal challenge with HSV-1 and HSV-2 wild type viruses (Stanfield et al.,
2014) . This vaccine is currently being tested by the National Institute of Allergy and Infectious
Diseases (NIAID), Vaccine and Treatment Evaluation Units (VTEUs) in Cincinnati.
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CHAPTER III: FUNCTIONAL HIERARCHY OF HERPES SIMPLEX VIRUS TYPE-1 (HSV1) MEMBRANE PROTEINS IN CORNEAL INFECTION AND VIRUS TRANSMISSION
TO GANGLIONIC NEURONS *
Introduction
Ocular herpes simplex virus (HSV) infection is one of the most common infectious
causes of blindness in developed countries. Moreover, frequent reactivation of latent virus can
cause recurrent herpes keratitis and corneal graft failure (Cockerham, 2001; Cockerham et al.,
1997; De Kesel et al., 2001; Liesegang, 2001; Liesegang et al., 1989; Tullo, 2003). Typically,
primary infection of epithelial cells exposed on orofacial mucocutaneous tissues leads to
invasion of embedded axonal termini embedded within the cornea via fusion of the viral
envelope with neuronal synaptic membranes. Subsequently, capsids are transported in a
retrograde manner to neuronal cell somata where viral genomes can establish life-long latency
(Antinone and Smith, 2010). Infrequently and particularly in newborn infections, neuronal
infection can cause acute encephalitis and significant morbidity and mortality (Fatahzadeh and
Schwartz, 2007). Immunosuppression as well as other external stimuli can cause reactivation of
the virus from the latent state and re-infection of peripheral tissues including corneas and
orofacial surfaces (Smith, 2012).

* This chapter previously appeared as Kim IJ & Saied AA, Chouljenko VN, Subramanian R,
Kousoulas KG, Functional hierarchy of herpes simplex virus type-1 membrane proteins in
corneal infection and virus transmission to ganglionic neurons. Curr Eye Res, 2014. 39(12): p.
1169-77. It is reprinted by permission of the Informa Healthcare. Saied AA is co-first author.
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Virion entry into all cells including neurons involves viral glycoproteins gD, gB, gH, gL,
and gC (Connolly et al., 2011). HSV-1 enters neuronal cells via a pH-independent fusion of the
viral envelope with neuronal axonal membranes (Nicola et al., 2005; Qie et al., 1999), while it
can enter a wide range of non-neuronal cells via either pH-independent or pH-dependent
endocytosis (Milne et al., 2005). Retrograde transport of capsids to neuronal somata after
infection of axonal termini is mediated by the dynein motor in conjunction with the neuronal
microtubular network (Diefenbach et al., 2008; Johnson and Baines, 2011; Mettenleiter et al.,
2009). Glycoprotein gB is thought to be the sole fusogenic glycoprotein, while glycoproteins gD
and gH/gL are required to activate gB’s fusogenicity in conjunction with specific cellular
receptors (Connolly et al., 2011). Binding of gD to its cognate receptors including nectin-1,
HVEM, and other receptors (Campadelli-Fiume et al., 2000; Geraghty et al., 1998; Montgomery
et al., 1996; Satoh et al., 2008; Shukla et al., 1999; Spear et al., 2000; Spear and Longnecker,
2003) triggers sequential conformational changes in gH/gL and gB causing fusion of the viral
envelope with cellular membranes during virus entry, as well as during virus-induced cell-to-cell
fusion (Hannah et al., 2007; Heldwein et al., 2006).
Wild-type virus strains typically cause limited but measurable amount of cell-to-cell
fusion in cell culture (Kousoulas et al., 1978). However, most viral lesions in human and animal
tissues are characterized by the presence of multinucleated cells (syncytia) (Goldgeier et al.,
2002; Roizman et al., 2007). Virus-induced cell-fusion is an important mechanism for virion
transmission to adjacent cells without exposure to the host humoral immune system,
particularly neutralizing antibody [reviewed in reference(Roizman et al., 2007)]. Extensive
membrane fusion can be induced by co-expressing glycoproteins gB, gD and gH/gL in cell lines
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indicating that gB, gD, and gH/gL are essential components for both virus entry and virusinduced cell fusion. (Muggeridge, 2000; Turner et al., 1998). Additional viral genes encode
proteins that have been shown to be involved in virus-induced cell fusion without necessarily
drastically affecting virus entry kinetics. These genes include: the UL20 gene (Baines et al.,
1991; McLean et al., 1990; Melancon et al., 2004), the UL24 gene (Jacobson et al., 1998;
Sanders et al., 1982), and the UL53 gene coding for gK (Bond and Person, 1984; Debroy et al.,
1985; Hutchinson et al., 1992; Pogue-Geile et al., 1984; Pogue-Geile and Spear, 1987; Ruyechan
et al., 1979). Also, certain mutations within the UL27 gene encoding glycoprotein gB drastically
enhance virus-induced cell-fusion presumably because they destabilize the virus-encoded
fusion machinery (Bzik et al., 1984; Pellett et al., 1985). We have shown that lack of either
glycoprotein gK or the membrane protein UL20 severely inhibits membrane fusion (Melancon
et al., 2004; Melancon et al., 2005). Moreover, we have shown that HSV-1 gK and UL20
functionally and physically interact and that these interactions are absolutely necessary for
their coordinate intracellular transport, cell-surface expression and membrane fusion functions
in the HSV-1 life cycle (Chouljenko et al., 2009; Chouljenko et al., 2010; Foster et al., 2001).
Glycoproteins gM and gE and the membrane-associated UL11 protein have been also
implicated in virus-induced cell fusion and virion egress (Chouljenko et al., 2012; Kim et al.,
2013). Glycoprotein gM is a conserved type III integral membrane protein with multiple
transmembrane domains, that forms a complex with pUL49.5 (gN) [reviewed in (Roizman et al.,
2007)]. Deletion of the gM gene does not abrogate HSV-1 replication, but does affect the ability
of the virus to spread (Leege et al., 2009). Expression of HSV-1, pseudorabies (PRV) and Kaposi
sarcoma associated herpesvirus (KSHV or HHV-8) gM and gN in transfected cells inhibited cell
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fusion caused by simultaneous expression of gB, gD, gH and gL glycoproteins (Klupp et al., 2000;
Koyano et al., 2003). Also, lack of gM was reported to inhibit virus-induced cell fusion caused by
a single amino acid substitution in the carboxyl terminus of gB (A855V; gBsyn) (Balan et al.,
1994). HSV-1 glycoprotein gE is expressed as a heterodimer with gI and functions to facilitate
cell-to-cell spread by sorting newly formed virion particles to cell junctions and lateral cell
surfaces (Collins and Johnson, 2003). Unlike PRV, HSV-1 gE-null viruses exhibited a retrograde
spread defect in vivo but not in vitro (McGraw et al., 2009).

UL11 is a 96-amino-acid

myristoylated and palmitoylated tegument protein anchored into the cytoplasmic side of cell
membranes (Baines et al., 1995; Baird et al., 2008; Loomis et al., 2001; MacLean et al., 1989).
UL11 interacts with viral glycoprotein gE and tegument proteins UL16 and UL21 and has been
suggested to play a role in recruiting viral proteins to the virion assembly site at the trans-Golgi
network (TGN) (Baird et al., 2008; Farnsworth et al., 2007; Han et al., 2012; Leege et al., 2009;
Loomis et al., 2001; Loomis et al., 2003). Although absence of UL11 in HSV-1 and PRV revealed
only moderate defects in viral replication (Chouljenko et al., 2012; Fulmer et al., 2007; Kopp et
al., 2003; Leege et al., 2009), the HCMV UL11 homologue is essential for virus replication (Seo
and Britt, 2007; Silva et al., 2003).
Recently, we showed that lack of either the gK or UL20 gene expression produced
significantly greater defects in virion envelopment and overall virus replication than deletion of
either the carboxyl terminus of gD, or lack of either UL11, gM or gE gene expression alone or in
various combinations (Chouljenko et al., 2012). Herein, we investigated the in vivo effects of
lack of either gE, gM, gK or UL11 using the scarified mouse eye HSV-1 infection model. The gKnull virus was unable to efficiently infect neurons and establish latency, in contrast to all other
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mutant viruses. Surprisingly, although the UL11-null virus replicated less efficiently mouse
corneas, it infected ganglionic neurons with greater efficiency than the gM and gE-null viruses.
These results suggest that in the scarified mouse eye model system, replication in the eye is not
directly associated with ability to infect neuronal endings and establish latency in ganglionic
neurons. Moreover, gK serves more important functions in neuronal infection than either gM,
gE or the UL11 protein.
Materials and Methods
Cells and viruses
African green monkey kidney (Vero) cells were obtained from the American Type
Culture Collection (Rockville, MD) and grown and propagated in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 5-10% fetal bovine serum (FBS) and antibiotics. The gKcomplementing VK302 cell line (generously provided by David Johnson, Oregon Health Sciences
University, Portland, OR) was maintained in DMEM supplemented with 10% FBS and antibiotics.
The HSV-1(F) cloned as a bacterial artificial chromosome was a gift from Dr. Kawaguchi
(Chouljenko et al., 2012; Lee et al., 2009; Tanaka et al., 2003; Tischer et al., 2006). All viruses
were grown on Vero cells and equal PFU were used for all viruses in the ocular infection
experiments. The gK-null virus was tittered on the VK302 complementing cell line.
Construction and characterization of recombinant viruses
The recombinant viruses were constructed in previous studies (Chouljenko et al., 2012;
Kim et al., 2013; Melancon et al., 2005). Briefly, mutagenesis was performed in E. coli using
113

two-step red mutagenesis implemented on HSV-1(F) strain cloned into the bacterial artificial
chromosome plasmid vector pYEbac102, as described previously (Kim et al., 2013). The gM-null
virus was constructed by altering two potential initiation codon sites (from ATG to CTG and from
ATG to ATT). The UL11-null and gE-null viruses were constructed by changing their respective
initiation codons from ATG to CTG, as described in detail previously (Kim et al., 2013) . The gKnull virus was constructed by replacing gK with a GFP-zeo gene cassette (Melancon et al., 2005).
All recombinant viruses were sequenced using next generation sequencing (NGS) to confirm the
introduction of the intended mutations and the absence of collateral unwanted nucleotide
changes, as described earlier (Kim et al., 2013).
Plaque morphology and viral yields of wild-type and mutant viruses
Confluent monolayers of Vero and VK302 cells were infected with WT BAC, ∆gM, ∆gE,
∆gK, ∆UL11 viruses at MOI of 0.001. Cells were fixed by methanol at 48 hpi. After fixation,
immunohistochemistry was performed using a horseradish peroxidase conjugated goat-antirabbit antibody (Dako Carpinteria, CA). The reactions were developed using NovaRed substrate
(VectorLabs, Burlingame, CA, USA).

Viral yields were obtained essentially as described

previously (Saied et al., 2013). Briefly, confluent monolayers of Vero cells were infected with
WT BAC, ∆gM, ∆gE, ∆gK, ∆UL11 viruses at MOI of 0.1. Infections were halted by freezing at 0,
24, and 48 hpi. Plates were prepared in triplicates and viral titers were determined for each
time point by standard plaque assay. Plaques were stained by immunohistochemistry and
visualized using dissecting microscope.
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Ocular infections
Balb/c mice were used for all experiments and were handled in accordance with the
ARVO statement for the use of animals in ophthalmic and vision research and Louisiana State
University-School of Veterinary Medicine IACUC regulations. Corneal scarification and ocular
inoculation of mice were performed as described previously (David et al., 2008; Saied et al.,
2014). Briefly; female Balb\c mice were divided into 6 groups; each group was inoculated with
either WT BAC, ∆gM, ∆gE, ∆gK, ∆UL11 viruses, or a mock-infected. After anesthesia, 25-26 G
needle was used to scarify mice corneas in a grid like pattern (4 cross hatches per eye).
Infections were performed using 105 PFU for each virus applied to each eye by a micropipette.
After inoculation, the eyelids were gently held shut for a few seconds. Clinical ocular changes
were monitored daily for keratitis, blepharoconjunctivitis and ocular discharge. Mice eyes were
rinsed at 24, 48 and 72 hours post infection and the number of infectious virions within the
rinsing solution was determined by plaque assay.
Quantitative PCR (qPCR) analysis
Trigeminal ganglia (TG) were collected 30 days post infection (dpi) for qPCR analysis and
stored at -80 °C. After thawing, Qiagen DNeasy blood and tissue kit (Qiagen, Valencia, CA) was
used to extract total DNA from the TG per manufactures instructions. QPCR was performed as
initially described previously for Kaposi’s sarcoma herpesvirus (KSHV) (Subramanian et al.,
2008; Subramanian et al., 2010) and utilized for HSV-1 DNA detection in neuronal cell cultures
(Kim et al., 2013). Briefly, the primers and probe (6-carboxytetramethylrhodamine (TAMRA) for
the real-time PCR were designed to detect HSV-1 US6 (gD). The amount of DNA extracted from
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each trigeminal ganglion was measured using Nanodrop spectrophotometer (Thermo Scientific,
Wilmington, DE). Total DNA concentration from each ganglion was approximately 80 ± 5 mg per
ganglion. Equal volumes of viral DNA were used for qPCR analysis. Purified plasmid containing
the gD gene was used to generate the standard curve.
Results
Comparison of the replication characteristics of recombinant viruses lacking gM, gE, UL11, or
gK.
The gM-null, UL11-null and gE-null (Figure 1) viruses were constructed previously via
mutagenesis of their respective initiation codons utilizing the cloned HSV-1(F) genome into a
bacterial artificial chromosome (WT BAC), while the gK-null was constructed via gene
replacement mutagenesis (Figure 1) (see ‘‘Materials and methods’’ section). The gK-null virus
formed very small plaques on Vero cells, while it was efficiently complemented and formed
much larger plaques on the VK302 cell lines expressing gK (Figure 2). The gE and gM-null viruses
produced viral plaques that on average were approximately 50% smaller, while the UL11-null
virus produced viral plaques that were approximately 75% smaller than the wild-type virus
(Figure 2). The replication kinetics of the gM and UL11-null viruses were similar yielding final
titers that were approximately one log less than the wild-type virus at 48 hpi. The gE-null virus
replicated with similar kinetics to the wild-type virus, while the gK-null virus replicated very
inefficiently yielding final titers that were at least three logs less than the wild-type virus at 48
hpi (Table 3.1).
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Figure 3.1: Schematic representation of mutant viruses. The top line represents the prototypic
arrangement of the HSV-1 genome with the unique long (UL) and unique short (US) regions
flanked by the terminal repeat (TR) and internal repeat (IR) regions. IGR denotes the intergenic
region. The relevant genome regions of the parental wild-type HSV-1(F) genome cloned as a bac
(WT BAC) and the gM, gE, and UL11-null viral genomes are shown. *Denotes mutagenesis of
initiation codons that prevent gene expression. The gK-null virus was constructed by replacing
the UL53 gene that encodes gK with a GFP-Zeo gene cassette under the control of the
cytomegalovirus IE promoter (CMV)(Melancon et al., 2005).
117

Figure 3.2: Plaque morphology of mutant viruses. Confluent monolayers of Vero or VK302 cells
were infected at an approximate MOI of 0.001 and representative plaques were identified as
indicated by immunohistochemistry staining. Viral plaques were photographed at the same
magnification. VK302 is a cell line expressing gK upon infection.
Table 3.1: Comparison of viral yields between wild type and recombinant viruses:
Virus\HPI
0 HPI
24 HPI
48 HPI
1
1
7
6
WT BAC
8.67x10 ± 6.67x10
4.87x10 ± 8.19x10
6x107 ± 2x107
gE-null
3.33x101 ± 1.76x101
4.93x107 ± 4.67x106
8.667x107 ± 1.764x107
gM-null
3.33x101 ± 1.33x101
9.33x106 ± 3.33x106
1.13x107 ± 1.76x106
UL11-null
3.33x101 ± 6.67
8.07x106 ± 8.82x105
1.13x107 ± 4.05x106
gK-null
6.67x101 ± 4.80x101
1.13x104 ± 3.52x103
2.47x104 ± 1.27x104
Table 3.1 shows viral yields in plaque forming units (PFU)/ml. Hours post infection (HPI).
Triplicate samples were titrated and the standard error of mean at each time point was
calculated.
Mouse eye infections
Mouse corneas were scarified and infected with 105 PFU in each eye. Clinical ocular
changes were monitored daily for the development of blepharoconjunctivitis, keratitis and
ocular discharge. Mice infected with the wild-type virus exhibited mild-clinical symptoms at 7
dpi, while none of the mice infected with the mutant viruses exhibited any significant ocular
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changes (Figure 3.3). Viral shedding was determined daily up to 72 hpi daily. The wild-type virus
produced the highest viral titers in eyewashes, followed by the gM-null, gE-null, UL11-null and
gK-null (Figure 3.4).

Figure 3.3: Clinical ocular disease development. Representative pictures of infected eyes are
shown. Mice eyes were monitored for the development of blepharoconjunctivitis, hyperemia,
keratitis and ocular discharge (A) WT BAC group, notice the blepharitis; thickening of upper and
lower eyelids (arrows). (B) gM-null group. (C) gE-null group. (D) UL11-null group. (E) gK-null
group (F) Mock group.

Determination of viral DNA in trigeminal ganglia of infected mice
The TG harboring latent viral DNA were collected from mice at 30 dpi and were tested
for the presence of viral DNA genomes by qPCR, as we have described previously (David et al.,
2012; Saied et al., 2013). On average, approximately 11,200 viral DNA genomes were detected
per single TG of mice infected with the wild-type virus. Viral genomes were detected in the TGs
of mouse infected with all mutant viruses except the gK-null-infected mice. Specifically, 2-of-10
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mice infected with the gM-null virus contained on average 600 viral genomes, 4-of-10 mice
infected with the gE-null virus contained on average 600 viral genomes, and 6-of-10 UL11-nullinfected mice contained on average 2400 viral genomes. The numbers of viral genomes
recovered from the wild-type infections were significantly different in comparison to all mutant
viruses by one-way ANOVA test (Figure 3.5).

Figure 3.4: Viral shedding. Viral titers were obtained from eye rinses obtained at 24, 48 and 72
hpi. DgK and Mock values are zeros.
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Figure 3.5: Viral DNA genome detection by qPCR. Equal volumes of viral DNA were used for
TaqMan PCR. Purified plasmid containing the gD gene was used to generate the standard curve.
Discussion
We have demonstrated previously that HSV-1 gK plays a pivotal role in neuronal
infection. Specifically, lack of gK prevents infection of TG after infection of scarified mouse eye
corneas, and inhibits retrograde and anterograde translocation of virions via neuronal axons
(David et al., 2008; David et al., 2012). The purpose of the present investigations was to
compare and contrast the ability of mutant viruses lacking gK, gM, gE, or UL11to productively
infected mouse corneas and ganglionic neurons in vivo and establish latency in the TG. Our
results confirm previous findings that lack of gK causes severe reduction in the ability of the
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virus to infect corneal cells and neurons despite the direct exposure of neuronal endings after
cornea scarification. In contrast, viruses lacking either gM, gE or UL11 infected mouse corneas
and established latent infections. Importantly, although the UL11-null virus replicated
inefficiently in mouse eyes, it infected ganglionic neurons and established latency more
efficiently than either the gM or gE-null viruses.
The wild-type HSV-1(F) virus produced only mild ocular changes after infection of mouse
eyes characterized by mild blepharoconjunctivitis only at late times post infection (7 days).
These results are significantly different to our previous findings that the HSV-1(McKrae) strain
produce drastic ocular changes marked by severe blepharitis, hyperemia, keratitis and high
ocular discharge 7-8 days post infection (Saied et al., 2014). The HSV-1(F) infection results are
consistent with previous findings that this viral strain was relatively apathogenic after
intracranial infection of mouse brains (Sedarati and Stevens, 1987). Moreover, the HSV-1(F)
strain utilized in the present investigations was recovered from the bac-cloned HSV-1(F)
genome (pYE102). Thus, it is possible that incorporation of the bac plasmid within the viral
genome contributed to the observed lack of ocular immunopathogenicity. The genomic
sequences of the HSV-1(F), KOS and McKrae strains have been obtained (Macdonald et al.,
2012a, b; Szpara et al., 2010). Alignment of the HSV-1(F) and McKrae genes encoding viral
glycoproteins reveals multiple single amino acid changes (Chowdhury et al., 2012). Additional
changes are predicted in many other genes when McKrae and F strains are compared (not
shown). One or more of these predicted amino acid changes may be responsible for the
observed ocular pathogenetic differences between these two viral strains.
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Mouse corneas contain over 50,000 neuronal axonal termini per mm2. Therefore, crosshatching scarification exposes neuronal endings to direct viral infection. In this regard, cornea
scarification provides a model for assessing the ability of viruses to directly infect ganglionic
neurons through their axonal termini. Using this model, we showed previously that lack of gK
drastically impaired the ability of the virus to infect ganglionic neurons and establish latency. In
this article, we confirm these findings and compare them to the ability of gM-, gE-, and UL11null viruses to infect ganglionic neurons. All three mutant viruses were able to infect ganglionic
neurons, albeit at reduced frequencies in comparison to the parental HSV-1(F) strain. These
results suggest that gM, gE and UL11 serve potentially secondary roles in corneal ganglionic
neuronal infections in comparison to gK. Surprisingly, although the UL11-null virus replicated
less efficiently in Vero cell monolayers and mouse eyes, it infected ganglionic neurons more
efficiently than the gM-null or gE-null viruses. This result supports our hypothesis that ocular
viral replication may contribute, but not serve the most important role in infection of ganglionic
neurons in the scarified mouse eye infection model system.
Recently, we showed that gM interacts with the gK/UL20 protein complex and that UL11
is required for virus-induced cell fusion caused by syncytial mutations in gB or gK, respectively
(Kim et al., 2013). Thus, the absence of either gM or UL11 from the virion particle may perturb
gB and gK/UL20 fusogenic functions preventing efficient entry into neuronal axons embedded
within scarified mouse corneas. Additional work is needed to directly demonstrate potential
defects in axonal cytoplasmic entry for these viruses. These experiments are currently in
progress.
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CHAPTER IV: A REPLICATION COMPETENT HSV-1(MCKRAE) WITH A MUTATION
IN THE AMINO-TERMINUS OF GLYCOPROTEIN K (GK) IS UNABLE TO INFECT
MOUSE TRIGEMINAL GANGLIA AFTER CORNEA INFECTION*
Introduction
HSV-1 causes multiple medical disorders such as cold sore, keratitis, encephalitis and
systemic disease (Whitley et al., 1998). The hallmark of the HSV-1 life cycle is infection of
sensory neurons, where the virus establishes a latent infection for the life of the host (Roizman
et al., 2007; Whitley et al., 1998). HSV-1 primary infection starts at the mucocutaneous surface
and then the virus invades the axonal termini to undergo retrograde transport to neuronal cell
body (Antinone and Smith, 2010). Upon, reactivation of the virus from the latent state, the
virus transports in anterograde manner to the periphery (Smith, 2012).
Ocular HSV is one of the most common infectious causes of blindness in developed
countries with estimates of the incidence of herpes ocular disease episodes ranging from 4.1 to
20.7 cases per 100,000 in developed countries. In the United States, approximately 500,000
people suffer from herpes simplex ocular disease (Liesegang, 2001; Liesegang et al., 1989). A
nationwide prospective study in France conducted in 2002 estimated the incidence of herpes
keratitis to be 25.8 cases per 100,000 persons annually (Labetoulle et al., 2005). Recurrent
herpes keratitis leads to corneal opacity and vision loss. Also, reactivation of latent virus from
the trigeminal ganglia (TG) can cause spread to corneal transplants causing corneal graft failure
(Cockerham, 2001; Cockerham et al., 1997; De Kesel et al., 2001; Tullo, 2003).
* This chapter previously appeared as Saied AA, Chouljenko VN, Subramanian R, Kousoulas KG.,
A replication competent HSV-1 (McKrae) with a mutation in the amino-terminus of glycoprotein
K (gK) is unable to infect mouse trigeminal ganglia after cornea infection. Curr Eye Res, 2014.
39(6): p. 596-603. It is reprinted by permission of Informa Healthcare.
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HSV-1 enters neuronal cells via a pH-independent fusion of the viral envelope with
neuronal plasma membranes (Nicola et al., 2005; Qie et al., 1999), while it can enter a wide
range of non-neuronal cells via either pH-independent or pH-dependent endocytosis (Milne et
al., 2005). Virus entry into all cells involves the coordinated functions of the glycoproteins gD,
gB, gH, gL, and gC (Connolly et al., 2011). Fusion of the viral envelope with cellular including
neuronal membranes causes deposition of the viral capsid into the cytoplasm, which is
subsequently transported to the cell nucleus. Retrograde transport of capsids to neuronal
somata after infection of axonal termini is highly dependent on the cellular microtubule
network and is most likely mediated via direct interactions by one or more tegument and
capsid proteins with the dynein motor and the dynein cofactor dynactin (Diefenbach et al.,
2008; Johnson and Baines, 2011; Mettenleiter et al., 2009).
The UL20 and UL53 (gK) genes are highly conserved in all alpha herpesviruses and
encode proteins of 222 and 338 amino acids, respectively, each with four membrane spanning
domains (Debroy et al., 1985; Foster et al., 2003; MacLean et al., 1991; Melancon et al., 2004;
Ramaswamy and Holland, 1992).

The amino and carboxyl termini of gK are located

extracellularly, while the amino and carboxyl termini of UL20 are located intracellularly (Foster
et al., 2003; Melancon et al., 2004).

gK is post-translationally modified by N-linked

carbohydrate addition at the amino-terminus of gK, while the UL20 protein (UL20p) is not
glycosylated (Debroy et al., 1985; Hutchinson et al., 1992; Ramaswamy and Holland, 1992).
HSV-1 gK is a structural component of virions and it interacts with UL20p on virion and cellular
membranes. HSV-1 gK and UL20 interaction is required for their coordinated intracellular
transport, cell surface expression, and functions in virus-induced cell fusion, virus entry, virion
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envelopment and egress from infected cells (Foster et al., 2003; Foster et al., 2008; Foster and
Kousoulas, 1999; Foster et al., 2004a; Foster et al., 2001a; Foster et al., 2004b; Hutchinson et
al., 1995; Jambunathan et al., 2011; Jayachandra et al., 1997). The amino terminus of gK
interacts with gB and gH and can complement gB-mediated cell fusion indicating that the
gK/UL20 protein complex can modulate virus entry and virus-induced cell fusion via modulating
gB and gH membrane fusion functions (Chouljenko et al., 2009; Chouljenko et al., 2010).
Virions that lack gK enter into African monkey kidney cells (Vero), albeit with lower
efficiency than the wild-type virus (Foster et al., 2001b; Jambunathan et al., 2011). Deletion of
amino acids 31-68 within the amino terminus of gK inhibits virus-induced cell-to-cell fusion and
virus entry without drastically inhibiting virion envelopment and egress.

Specifically, a

recombinant virus lacking gK amino acids 31-68 replicated fairly efficiently, while gK deletions
from amino acids 31-47 and 31-117 exhibited major defects in infectious virus production
(Chouljenko et al., 2009). However, deletion of gK amino acids 31-68 inhibited virus-induced
cell fusion caused by syncytial mutations in gK and entry into PILR-alpha expressing Chinese
hamster ovary cells (Chouljenko et al., 2009; Chowdhury et al., 2013). We have shown that gK
is essential for neuronal infection and virulence (David et al., 2008). Specifically, we have
reported that gK-null virus was unable to infect axonal termini and egress from neuronal cell
bodies (David et al., 2012).
To further investigate the role of gK in neuroinvasiness, we engineered the gK 31-68
amino acid deletion in the HSV-1(McKrae) genome cloned as a bacterial artificial chromosome
(McK). In vivo experiments utilizing the mouse eye model system revealed that this virus was
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unable to efficiently infect mouse TG after ocular infection of scarified mouse eyes. These
results indicate that the amino terminus of gK plays pivotal role in corneal infection,
neuroinvasiveness and acute herpes keratitis.
Materials and Methods:
Cells and viruses
African green monkey kidney (Vero) cells were obtained from the American Type
Culture Collection (Rockville, MD) and grown in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 5-10% fetal bovine serum (FBS) and antibiotics. The gK-complementing
VK302 cell line (generously provided by David Johnson, Oregon Health Sciences University,
Portland, OR) was maintained in DMEM supplemented with 10% FBS and antibiotics. The
clinical ocular isolate and the neuroinvasive strain of HSV-1 (McKrae) was a gift from J. M. Hill
(Louisiana State University Health Sciences Center, New Orleans, LA).
Construction and characterization of recombinant viruses
The McKrae strain of HSV-1 was originally cloned into a bacterial artificial chromosome
(BAC) vector. The construction methodology for mutant viruses for this experiment is
essentially similar to the techniques that were previously described (Chowdhury et al., 2013;
Tanaka et al., 2003). Briefly, the BAC plasmid PBeloBAC 11 (NEB) was inserted between the UL3
and UL4 viral genes. An excisable EGFP cassette bracketed by flippase recognition target (FRT)
sequences was cloned into the BAC plasmid vector. Vero cells were transfected with the
plasmid vector and infected with HSV-1 (McKrae) virus. Fluorescent plaques were selected and
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the presence of BAC plasmid was confirmed by PCR-assisted DNA sequencing (Chowdhury et
al., 2013). The recombinant virus McK∆gK31-68 was constructed by deleting 38 amino acids (gK
amino acids 31- 68) from the amino terminus of gK as described previously for the HSV-1 (F)
genome cloned into BAC plasmid pYEbac102 (Tischer et al., 2006). During the construction of
this virus the EGFP gene is spontaneously removed via FRT-mediated recombination. A rescued
virus was also produced by transfection of a gene segment spanning the gK gene followed by
infection with a gK mutant virus. All viruses were sequenced using the Ion Personal Genome
Machine (PGM) sequencer (Life Technologies-Invitrogen, Carlsbad, CA) to confirm the ∆gK31-68
deletion and the absence of any other nucleotide changes within coding sequences.
Plaque morphology and replication kinetics of wild-type and mutant viruses
For plaque size and morphology, confluent monolayers of Vero and VK302 cells were
infected with McK, McKR (rescued virus), or McK∆gK31-68 viruses at MOI of 0.001. Cells were
fixed by methanol at 48 hpi. After fixation, immunohistochemistry was performed using a
horseradish peroxidase conjugated goat-anti-rabbit polyclonal antibody (Dako Carpinteria, CA).
The reactions were developed using NovaRed substrate (VectorLabs, Burlingame, CA, USA).
Replication kinetics were determined as described previously (David et al., 2008; David et al.,
2012). Briefly, confluent monolayers of Vero cells were infected with McK, McKR, or McK∆gK3168 viruses at MOI of 1. Infections were stopped by freezing at 0, 6, 12, 18 and 24 hours post
infection (hpi). Plates were prepared in triplicates and viral titers were determined for each
time point by standard plaque assay. Plaques were stained by immunohistochemistry and
visualized using a dissecting microscope.
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Animals
Female BALB\c mice (6-to-10-week-old) were divided into four groups; each group was
infected with McK, McKR, McK∆gK31-68 viruses, or mock-infected. All animals were handled in
accordance with the ARVO statement for the use of animals in ophthalmic and vision research
and Louisiana State University-School of Veterinary Medicine IACUC regulations. Animals were
anesthetized, and the corneas were scarified in a grid pattern using a 25-26 G needle as
described previously (David et al., 2008). Each eye was inoculated with 105 plaque forming
units (pfu) applied using a micropipette. After inoculation, the eyelids were gently held shut for
a few seconds. The clinical ocular disease development and progression were monitored and
scored daily. The scoring criteria included the degree of blepharoconjuctivitis, hyperemia,
keratitis and ocular discharge. The ocular disease was scored on a scale of 0-3. Zero
represented a normal eye with no clinical symptoms, and 3 represented severe clinical
presentation of the ocular changes.
Quantitative PCR analysis
TG were collected 30 days post infection (dpi) for quantitative PCR (qPCR) analysis and
stored at -80° C. After thawing, trigeminal ganglia were processed using the Qiagen DNeasy
blood and tissue kit (Qiagen, Valencia, CA) to isolate total DNA per the manufacturer’s
instructions. qPCR was performed as initially described previously for Kaposi’s sarcoma
herpesvirus (KSHV) (Subramanian et al., 2008; Subramanian et al., 2010) and subsequently
utilized for HSV-1 DNA detection in neuronal cell cultures (David et al., 2012). Briefly, the
primers and probe (6-carboxytetramethylrhodamine (TAMRA) for the real-time PCR were
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designed to detect the HSV-1 US6 (gD). Equal amounts of total DNA were used for TaqMan PCR
analysis. A baseline cutoff value of 0 was set at approximately 50 genomes, since samples
containing less than 50 genomes exhibited high variability among the triplicate samples.
Purified plasmid containing the gD gene was used to generate standard curves as described
previously (David et al., 2012).
Infectious viral particle recovery
TG explants were collected from mice 30 dpi and were incubated at 37° C and 5% CO2
immersed in DMEM media with no FBS for 48 hrs. Then, ganglia explants were macerated and
co-cultured with Vero cells for another 48 hrs. Virus stocks were prepared and the number of
infectious virions was determined by standard plaque assay.
Results
Construction and characterization of recombinant viruses
Construction and characterization of the McK virus was described previously
(Chowdhury et al., 2013). This virus has a bac containing a EGFP gene cassette inserted within
the intergenic region between the UL3 and UL4 genes (Figure 4.1A). The McK genome was
utilized to engineer the McK∆gK31-68 (Figure 4.1B) virus using the two-step red-mediated
recombination (Tischer et al., 2006). Subsequently, a rescued virus (McKR) was constructed
(Figure 4.1C). Lack of spurious mutations and confirmation of the engineered mutations was
obtained by complete genomic sequencing of all engineered viruses (see Materials and
Methods section).
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The wild-type (McKrae), McK and the McKR viruses produced on average similar plaque
sizes on Vero cells (Figure 4.2 A, B, C). However, the McK∆gK31-68 virus consistently produced
plaques that were on average approximately half-the-size of the McK and the McKR viruses
(Figure 4.2D). The McK∆gK31-68 smaller plaque size phenotype was reversed on the gK
expressing cells VK302 on which all viruses produced on average similar size plaques (Figure 4.2
I, J, K, L). As expected, only the McK virus exhibited EGFP fluorescence (Figure 4.2 F, N). The
McK, McK∆gK31-68 and McKR viruses replicated with similar kinetics in Vero cells at an MOI of
1 with the exception that the McK∆gK31-68 appeared to have a delay in infectious virus
production at 6 hpi in comparison to the McK and McKR viruses that did not negatively affect
infectious virus production at later times post infection (Figure 4.3).

Figure 4.1: Schematic representation of mutant viruses. The top line represents the prototypic
arrangement of the HSV-1 genome with the unique long (UL) and unique short (US) regions
flanked by the terminal repeat (TR) and internal repeat (IR) regions. (A) McK. (B) McK∆gK31-68.
(C) McKR.
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Figure 4.2: Plaque morphology of the constructed viruses. Confluent monolayers of Vero cells
were infected at an MOI of 0.001 and representative plaques were identified and visualized
after immunhistochemical staining (see Materials and Methods). Representative viral plaques
of HSV-1(McKrae) and the derived mutant viruses are shown (A-D & I-L). Representative
fluorescent plaques were visualized using fluorescence microscopy (E-H & M-P).
Mouse eye infections
Mice corneas were scarified and infected with 105 pfu for each eye. The ensued
development of clinical ocular changes and disease progression were monitored and scored.
The first signs of ocular changes started to appear at 4 dpi characterized by blepharospasms
and small amounts of ocular discharges. These symptoms progressed and peaked at 7-8 days
post infection. The clinical symptoms regressed and started to wane until relative resolution at
30 dpi. Specifically, the ocular clinical symptoms of blepharoconjunctivitis, hyperemia, keratitis
and ocular discharge were the criteria used for scoring (see Materials and Methods section).
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Figure 4.3: Replication kinetics of parental and mutant viruses. Confluent monolayers of Vero
cells were infected at an approximate MOI of 1 with McK, McKR, or McK∆gK31-68 viruses.
Infection was halted at the indicated time points and viral titers were obtained.
Infection of mouse eyes with the McK virus produced progressive ocular changes
characterized as mild clinical ocular symptoms (score 1) at 3 days post infection (dpi), moderate
blepharitis, hyperemia and ocular discharge (score 2) at 6 dpi, and acute ocular disease (score
3) at 9 dpi. In contrast mock-infected eyes, or eyes infected and observed immediately after
infection, had no apparent ocular changes and were scored as 0 (Figure 4.4 A, B, C, D). Mouse
eyes infected with the McK∆gK31-68 virus did not show any significant ocular disease
symptoms throughout the thirty-day-long observation post infection (not shown).
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Figure 4.4: Clinical ocular disease development and scoring: Representative photographs of
eyes exhibiting different lesion scores are shown. Scoring criteria included the degree of
blepharoconjunctivitis, hyperemia, keratitis and ocular discharge (A) Score 0: Normal. (B) Score
1; Mild. (C) Score 2; Moderate. (D) Score 3; Severe.

TG-associated viral DNA and infectious virions
The TG were collected from mice at 30 dpi and tested for the presence of viral DNA
genomes by qPCR, as we have described previously (David et al., 2012). Over 600 viral DNA
genomes were detected in the TGs of mice infected with McK, or the McKR viruses; however,
no viral DNA was detected in the TGs of mice infected with McK∆gK31-68, or mice in the mockinfected groups (Figure 4.5 A).
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TG explants were co-cultured with permissive cells (Vero cells) for 48 hrs to allow for
viral reactivation. Infectious viral particle recovery was assessed by the standard plaque assay.
All TGs from mice infected with McK and 70% of TGs from mice infected with McKR produced
high numbers of infectious viral particles. However, substantially lower numbers of infectious
virions were recovered only from two-of-ten of the mice infected with the McK∆gK31-68 virus
(Figure 4.5 B).

Figure 4.5: Viral DNA genome detection by qPCR and infectious viral particle recovery from
TGs. A) TG samples were taken 30 dpi. The Viral DNA copy numbers were determined by qPCR.
Purified plasmid containing the gD gene was used to generate the standard curve. B) Trigeminal
ganglia explants were triturated and co-cultured with permissive cells (Vero cells) and viral
titers were obtained by standard titration plaque assay on Vero cells. TG samples were
collected 30 dpi.
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Discussion
We have demonstrated previously that HSV-1 gK plays a pivotal role in neuronal
infection and the ability of the virus to translocate in a retrograde manner from infected mouse
corneas to the TG, while lack of gK also prevents virus to be transported in an anterograde
manner (David et al., 2008; David et al., 2012). The purpose of the present study was to
investigate whether a relatively small deletion in the amino terminus of gK, which is known to
bind to the amino terminus of gB and modulate gB’s fusogenic properties, could confer similar
defects in neuronal infection and spread observed by viruses lacking gK gene expression. The
results presented herein show that the amino terminal segment of gK spanning amino acids 3168 that includes two N-glycosylation sites is required for neuronal infection and acute
inflammatory responses responsible for herpes keratitis.
Previous studies using the HSV-1(F) genome cloned as a bac have identified the amino
terminus of gK as an important determinant for virus-induced cell fusion, virus entry and virus
spread (Chouljenko et al., 2009; Chowdhury et al., 2013; Foster et al., 2008; Foster et al., 2001b;
Jambunathan et al., 2011; Jayachandra et al., 1997). However, HSV-1(F) does not cause
significant ocular disease in the mouse eye model (not shown). Therefore, we have chosen to
work with the human HSV-1(McKrae) viral strain, because it causes acute disease and death in
experimental infections of mice via the eye route with or without cornea scarification (David et
al., 2008). The HSV-1(McKrae) was cloned as a bac (McKbac) to facilitate the isolation of
recombinant viruses using the double-red mutagenesis procedure (Tischer et al., 2006).
Insertion of the bac between the UL3 and UL4 genes appeared to reduce virus-induced
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mortality in an infectious dose dependent manner (not shown); however the McK remained
highly pathogenic inducing acute herpes keratitis in infected mouse eyes. In agreement with
previous findings using the HSV-1(F) virus, deletion of aa 31-68 from the amino terminus of gK
did not drastically impair the virus ability to produce infectious virions (Chouljenko et al., 2009).
We chose to scarify the mouse eyes prior to infection in order to expose a significant
number of neuronal axonal termini embedded within mouse corneas to direct infection by the
virus. The cornea is one of the most densely innervated tissues in the mouse and human body.
This highly innervated tissue protects the cornea and the eye from the external environment
(Belmonte and Gallar, 1996; Wang et al., 2012). Cross-hatching scarification exposes a
significant number of axons to direct viral infection. Surprisingly, infection of scarified mouse
eyes with the McK∆gK31-68 virus failed to efficiently infect mouse TG, in comparison to the
parental virus. Specifically, qPCR failed to detect viral DNA in mouse TGs; however, very low
numbers of virions were recovered in 2-of-10 mice infected with the McK∆gK31-68 virus. This
discrepancy is attributed to the inability of qPCR to reproducibly and reliably detect less than 50
copies of viral genomic DNA in ganglionic extracts (not shown), while explant-reactivation coculture experiments can amplify a low number of virions during the ganglia incubation at 37° C
(48 hours) and during the subsequent co-culture on Vero cells (48 hours). Thus, few reactivating
genomes can result in the observed titers produced by explant culture of the two McK∆gK31-68
virus-positive mouse ganglia.
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Importantly, mice infected with McK developed severe blepharoconjuctivitis,
hyperemia, keratitis and marked ocular discharge 7-8 days post infection. Whereas, mice
infected with McK∆gK31-68 virus did not show significant clinical ocular changes. These results
suggest that efficient translocation of the virus to TG may be prerequisite to the causation of
acute inflammatory responses and herpes keratitis. It has been reported that immunization of
mice with gK significantly exacerbated inflammation, corneal scaring and facial dermatitis
following ocular HSV-1 infection (Ghiasi et al., 1995; Ghiasi et al., 1997; Ghiasi et al., 1994a;
Ghiasi et al., 1994b). Therefore, it is also possible that the amino terminus of gK is involved in
the induction of innate immune responses that result in acute inflammation and herpes
keratitis. This hypothesis is also supported by the observations that a recombinant virus
expressing extra copies of gK caused elevated levels of inflammation and corneal scaring in
both mice and rabbits (Mott et al., 2007b). Moreover, it was reported that elevation of anti-gK
antibody in individuals with a history of HSV-1 recurrence was correlated with increased
severity of eye disease (Mott et al., 2007a). Additional experiments are required to elucidate
the role of gK in neuronal infection and herpes keratitis.
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CHAPTER V: CONCLUDING REMARKS
Summary
Herpes simplex virus type 1 (HSV-1) is a neurotropic pathogen of humans responsible
for a wide spectrum of clinical disease, ranging from vesicular lesions on the lips to sight
threatening keratitis, and fatal encephalitis and disseminated disease. The hallmark of the HSV1 life cycle is infection of sensory neurons, where the virus establishes a latent infection for the
life of the host (Roizman et al., 2007).
HSV-1 viral particle consists of a double stranded DNA genome enclosed in an
icosahedral capsid. The capsid is surrounded by a proteinaceous tegument and an envelope
derived from cell membranes. The viral envelope is studded with 12 glycoproteins that function
in multiple aspects of viral life cycle and host interaction (Roizman et al., 2007).
Glycoprotein K (gK) is an envelope glycoprotein that has been the main focus of my PhD
research work. Specifically, I studied the role of gK and its functional domains in neuroinvasion
and immunopathogenesis of keratitis. Glycoprotein K has been shown to be involved in viral
envelopment, fusion, egress and spread (Hutchinson et al., 1992; Hutchinson and Johnson,
1995; Jambunathan et al., 2011; Jayachandra et al., 1997; Melancon et al., 2005). Other
glycoproteins such as gE, gM and the membrane protein UL11 have also been shown to play
roles in viral envelopment, fusion, egress and spread (Chouljenko et al., 2012; Han et al., 2012;
Kim et al., 2013; Leege et al., 2009). To explore the relative importance of these membrane
proteins (gK, gE, gM, and UL11) in infection of mouse corneas and establishment of latency in
ganglionic neurons, we constructed recombinant mutant viruses that lack the expression of
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either gK, gE, gM, and UL11 and compared them to the wild type parental virus. The
recombinant viruses were constructed using a markerless two-step Red-mediated
recombination system implemented on a bacterial artificial chromosome (BAC). The mutant
viruses were sequenced to assure that no collateral extraneous mutations were introduced.
The wild type and the recombinant viruses were used to infect mice via the ocular route. The
mutant viruses were also characterized by using plaque morphology to assess virus spread, viral
growth kinetics to measure infectious virus production, viral shedding in tear film after ocular
inoculation, quantitative PCR analysis for the quantification of viral genome copy numbers in
the trigeminal ganglia. The wild type virus and all the recombinant viruses except gK-null
mutant were able to infect axonal termini embedded in the cornea and establish latency in
ganglionic neurons albeit with varied efficiency. This result suggests that gK plays the most
important role in neuroinvasiveness. UL11-null virus replicated in the eyes less efficiently than
gM-null and gE null mutants, however, it infected ganglionic neurons and established latency
more efficiently than either the gM or gE-null viruses (Kim et al., 2014).
Recent work in this research laboratory has shown that gK is essential for viral corneal
spread and neuroinvasiveness (David et al., 2008). Previously, I participated in the development
of a primary neuronal culture system to study the role of gK in axonal infection and viral
transport in retrograde and anterograde manner in neurons. Primary neuronal cultures were
prepared from the dorsal root ganglia of embryonic rats. A single cell suspension of neurons
was plated in microfluidic devices that separate neuronal bodies from pure axonal fraction. We
utilized this microfluidic system to show that gK is required for infection of axonal termini and
egress from neuronal cell bodies in primary neuronal cultures (David et al., 2012).
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The above mentioned investigations revealed that deletion of the entire gK gene
resulted in drastic decrease in viral replication and spread efficiencies. A viral backbone that
lacks gK constitutes a safe viral vector; however, low replication and spread efficiencies would
be considered major disadvantages. Therefore, I sought to delineate gK domains responsible for
neuroinvasion and replication as well as immunopathogenesis of keratitis. The highly
pathogenic and neuroinvasive clinical ocular isolate of HSV-1 McKrae strain, was used to
construct a recombinant mutant virus lacking 37 amino acids from the amino terminus of gK,
amino acids (31-68). This recombinant virus and its parent wild type were characterized by
using plaque morphology to assess virus spread, viral growth kinetics to measure infectious
virus production, and by quantitative PCR analysis for the quantification of viral genome copy
numbers in the trigeminal ganglia. Experiments in this investigation (outlined in chapter IV of
this dissertation) showed that the amino terminus of gK is dispensable for replication in tissue
culture, but important for neuroinvasion and establishment of latency after ocular inoculation
of mice (Saied et al., 2014).
One important observation from the above investigation is that mice infected with the
wild type virus developed severe keratitis, conjunctivitis, blepharitis and ocular discharge. On
the other hand, mice infected with the recombinant virus lacking the amino terminus of gK did
not exhibit significant ocular changes (Saied et al., 2014). This observation suggests a potential
role for the amino terminus of gK in immunopathogenesis of keratitis. The investigation of the
role of the amino terminus of gK in immunomodulation of keratitis is currently in progress. The
preliminary results obtained so far are included in Appendix I.
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In conclusion, the research work in this dissertation is considered a significant
contribution to our understanding of alphaherpesvirus virulence factors and neurotropic
determinants. It may lead to the development of a safe, replication competent viral vector
backbone for oncolytic viral therapy and vaccine. The research work presented in this
dissertation may also lead the discovery of new therapeutics to treat herpes keratitis, and to
find new ways to combat neuronal infections.
Current and Future Research
Current work is focused on answering another critical question; is gK that lacks the 37
amino acids from the amino terminus expressed on the virion particle? To answer this question,
I have constructed a recombinant virus that has a deletion in the amino terminus of gK and also
carries a V5 tag on its carboxyl terminus. gK is extremely hydrophobic, and notoriously difficult
to detect. The purpose of tag insertion is to facilitate detection in various types of experiments.
Sequencing of this virus showed that the V5 tag is inserted in the intended location and that no
amino acid changing mutations were introduced. We are currently working on showing the
expression of tagged gK (31-68) in the virion particle by western blot analysis on purified
virions. Concurrently, I am studying the mechanism by which gK is involved in
immunomodulation of keratitis (please see Appendix I).
The work in this dissertation raised important research questions about the critical
amino acid requirements in the amino terminus of gK that are responsible for neuroinvasion
and immunopathogenesis. Glycoprotein K is post-translationally modified by N-linked
carbohydrate addition at the amino-terminus. The segment spanning amino acid (aa) 31 to aa
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68 in the amino terminus of gK contains two N-linked glycosylation sites at aa 48 and aa 58.
Future research could delineate the gK critical amino acids and the role of N-glycosylation in gK
function.
Another interesting and very important question to address is the mechanism by which
gK functions in virion entry at the axonal termini. This research question can be investigated by
studying the effects of gK mutations on gB conformation, and by assessing the role of cellular
receptors and signaling pathways in gK-mediated virus entry into axonal termini.
The secondary structure of gK presents Domain II as a loose cytoplasmic domain with a
couple of membrane anchored amino acids. However, the modeled tertiary structure of gK
predicts that Domain II is composed of two connected alpha helices. This is particularly
interesting because it reveals that this portion may not be a mere structural domain. It may also
have an important function which merits further investigation.
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APPENDIX I: ADDITIONAL WORK
Introduction
HSV-1 causes multiple medical disorders such as cold sore, keratitis, encephalitis and
systemic disease (Roizman et al., 2007; Whitley et al., 1998). It is the leading infectious cause of
corneal blindness in the US. An estimated 400,000 people in the US suffer from herpes simplex
ocular disease, with about 50,000 new or recurrent cases occurring annually. HSV-1 infects
sensory neurons and establishes a latent infection in the trigeminal ganglia (Roizman et al.,
2007; Whitley et al., 1998). Reactivation of latent virus from the trigeminal ganglia can cause
spread to corneal transplants causing corneal graft failure (Cockerham, 2001).
The envelope of the HSV-1 virion particle contains 12 glycoproteins as well as several
membrane-associated proteins, which play important roles in viral entry and virus-induced cell
fusion (Roizman et al., 2007) . HSV-1 glycoprotein K (gK) is a structural component of the virion
particle and functions in virus entry into epithelial cells (Foster et al., 2001; Jambunathan et al.,
2011) cytoplasmic virion envelopment, virion egress, and virus-induced cell fusion (Chouljenko
et al., 2009). Glycoprotein K exerts its function in virus entry by modulation of gB, the bona fide
fusogen of HSV-1 (Chouljenko et al., 2009). HSV-1 gB has been shown to interact with TLR-2
which leads to pro-inflammatory cytokine production via MyD88 dependent signaling (Cai et al.,
2013).
Corneal epithelial cells are one of the most important participants in herpes simplex
keratitis (HSK). They not only take part in pathogen recognition via the expression of a wide
range of pattern recognition receptors (PRR) including Toll-like receptors (TLR) TLR-2, and TLR156

7, but also secrete β-defensins, cytokines and chemotactic factors upon microbial invasion
(Johnson et al., 2005; Kumar et al., 2006).
We have reported that mice infected with wild type virus (wt) exhibited significant
clinical ocular changes and keratitis while mice infected with a recombinant virus lacking the
amino terminus of gK (McK ∆gK 31-68) did not show significant ocular disease (Saied et al.,
2014) (Figure AI.1). In this work, we describe a novel immuno-modulatory role for gK in the
immunopathogenesis of HSK.

Figure AI.1: Ocular infection of mice. Infection of mice eyes with the wt virus produced
progressive ocular changes characterized by severe blepharitis, keratitis, hyperemia and ocular
discharge seen in top right panel. Histopathological examination of the eyes revealed that the
cornea is infiltrated by a large number of neutrophils, lymphocytes, plasma cells and
macrophages and neovascularization is noted, bottom right panel. Infection of mice eyes with
McK ∆gK 31-68 virus produced no significant ocular disease shown in top left panel. The cornea
shows no significant histopathological changes in eyes infected with McK ∆gK 31-68 virus,
bottom left panel. L: lens, C: cornea, E: 3rd eylid.
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Objectives and Hypothesis
The objective of this work is to investigate the role of the amino terminus of gK in the
induction of the innate signaling pathways that are involved in herpes immunopathogenesis of
keratitis. We hypothesize that the lack of the amino terminus of gK alters gB binding to TLR-2
which leads to TLR-2 mediated immunomodulation.
Materials and Methods
Viruses
The highly pathogenic and neuroinvasive wild type HSV-1 virus McKrae strain cloned
onto a bacterial artificial chromosome plasmid vector (designated as wt) was used as a back
bone to construct a recombinant virus that lacks the amino terminus of glycoprotein K
(designated as McK ∆gK 31-68) virus. Two-step red mutagenesis implemented on the wt virus
was performed to construct McK ∆gK 31-68 virus.
Toll-like receptor-2 (TLR2) stimulation
HEK-Blue™-hTLR2 cells (bought from InvivoGen) were used to study the stimulation of
TLR2 by monitoring the activation of NF-kB. HEK-Blue™-hTLR2 cells are HEK293 cells cotransfected with human TLR2 (hTLR-2) and SEAP (secreted embryonic alkaline phosphatase)
reporter genes. Levels of SEAP were determined using a detection medium with SEAP substrate
QUANTI-Blue™. The hydrolysis of the substrate by SEAP produces a purple/blue color that can
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be measured with a spectrophotometer. HEK-Blue™ Null1 cell line (bought from InvivoGen) is
the parental cell line of HEK-Blue™ hTLR2. HEK-Blue™ Null1 cells lack the expression of TLR-2
but express the SEAP reporter gene.
QPCR analysis
qPCR analysis to determine the levels of mRNA transcription of pro-inflammatory
cytokines and interferon genes was performed on; HEK-Blue™-hTLR2 cells, HEK-Blue™ Null1
cells and Human corneal epithelial (HCE) cells lysates. The pro-inflammatory cytokines and
interferon genes; TNF- α, IL-6, IL-10, and IFN-B were selected for the qPCR procedure.
Detection of NF-kB activation by western blot
Western blot analysis was performed on human corneal epithelial cells to determine the
activation of the transcription factor NF-kB using IKB-α as a proxy for NF-kB activation.
Antibodies for IKB- α detection were purchased from abcam, USA.
Results
Toll-like receptor-2 (TLR2) stimulation
McK ∆gK 31-68 virus induces marked NF-kB activation in HEK-Blue-TLR2 cells compared
to wt virus. There is no marked difference in NF-kB activation between wt virus and McK ∆gK
31-68 virus in infected HEK-Blue Null1 cells (Figure AI.2).
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Figure AI.2: NF-kB activation. HEK-Blue-TLR2 and HEK-Blue Null1 cells were infected with either
McK ∆gK 31-68 virus or wt virus, a detection medium with SEAP substrate was added to the
Supernatants from infected cells were added 18 hrs post infection. Changes in optical density
were measured by a spectrophotometer. McK ∆gK 31-68 virus causes 8-8.5 fold increase in
optical density in HEK-Blue-TLR2 cells compared to wt virus. Activation levels of NF-kB in HEKBlue Null1 cells are similar for both viruses. TLR-2: HEK-Blue-TLR2 cells. Null: in HEK-Blue Null1
cells.
QPCR analysis for pro-inflammatory cytokine mRNA transcripts in HEK blue cells
Lack of the amino-terminus of gK is associated with increased pro-inflammatory
cytokine mRNA levels in HEK-Blue-TLR2 cells (Figure AI.3). Greater mRNA levels of TNF- α, IL-6
and IFN- β were detected in HEK-Blue-TLR2 cells infected with McK ∆gK 31-68 compared to wt
virus. Generally, mRNA levels of TNF- α and IFN- β were similar in HEK-Blue™ Null1 cells
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infected with McK ∆gK 31-68 compared to wt virus. The production of large numbers of proinflammatory cytokine and IFN-β mRNA transcripts after NF-kB activation is overwhelmingly
due to TLR-2 pathway engagement in HEK Blue cells (Figure AI.4).

Figure AI.3: QPCR analysis-HEK blue cells. HEK Blue TLR-2 and HEK Blue Null1 cells were infected
at a multiplicity of infection (MOI) of 5 with either wt or McK ∆gK 31-68 virus. RNA was
extracted at multiple different points post infection and mRNA transcripts copy numbers of proinflammatory cytokines were determined by QPCR. TLR-2: HEK-Blue-TLR2 cells. Null: HEK-Blue
Null1 cells. Asterisks denote statistical significance. Threshold significance level is 0.05. HPI:
hours post infection.
Determination of NF-kB activation in HCE by western blot
McK ∆gK 31-68 virus prompts more NF-kB activation than the WT virus at early time
points in HCE cells (Figure AI.5).
QPCR analysis for pro-inflammatory cytokine mRNA transcripts in HCE cells
Lack of the amino-terminus of gK is associated with increased pro-inflammatory
cytokine mRNA levels in HCE cells (Figure AI.6). TNF- α and IL-6 mRNA transcripts were
significantly higher in HCE cells infected with the McK ∆gK 31-68 than cells infected with the wt
virus.
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Figure AI.4: QPCR analysis, TLR-2 engagement. Since NF-kB can be activated by TLR-2
engagement as well as other pathways, we divided mRNA transcription levels obtained from
infection of HEK Blue-TLR-2 cells by the mRNA transcription levels obtained from infection of
HEK Blue Null1 cells. This will help distinguish the impact of TLR-2 engagement in the activation
of NF-kB and the production of inflammatory cytokine and IFN-β. TLR-2: HEK-Blue-TLR2 cells.
Null: HEK-Blue Null1 cells. Asterisks denote statistical significance. HPI: hours post infection.
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Figure AI.5: Western blot for NF-kB activation in HCE cells. IKB-α was used as a proxy for NF-kB
activation. McK ∆gK 31-68 virus induces more NF-kB activation than wt virus at early time
points. HCE cells: Human corneal epithelial cells.

Figure AI.6: QPCR analysis-HCE cells. HCE cells were infected at a multiplicity of infection (MOI)
of 5 with either wt or McK ∆gK 31-68 virus. RNA was extracted at multiple different time points
post infection and mRNA transcripts copy numbers of pro-inflammatory cytokines were
determined by QPCR. Asterisks denote statistical significance. Threshold significance level is
0.05. HPI: hours post infection. HCE: human corneal epithelial cells.
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Summary
Lack of the amino-terminus of gK alters NF-kB activation which indicates that gK is
potentially involved in the immunomodulation of herpes keratitis. McK ∆gK 31-68 induces
marked NF-kB activation than the wt virus. Subsequently, greater pro-inflammatory cytokine
mRNA transcripts were detected in cells infected with McK ∆gK 31-68 than the wt virus at early
time points. The global gene expression dynamics of viral as well as host mRNA transcripts are
being studied using digital PCR and RNA seq. Lack of the amino terminus of gK my alter gB
binding to TLR-2 which leads to TLR-2 mediated immunomodulation. Future studies may
involve the detection of conformational changes in gB using a cadre of monoclonal antibodies
and confirm of the engagement of TLR-2 pathway.
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